Pharmaceutical chemistry and technology Books

199 products


  • Pharmaceutical Extrusion Technology

    Taylor & Francis Inc Pharmaceutical Extrusion Technology

    Out of stock

    Book SynopsisThe first edition of Pharmaceutical Extrusion Technology, published in 2003, was deemed the seminal book on pharmaceutical extrusion. Now it is expanded and improved, just like the usage of extrusion has expanded, improved and evolved into an accepted manufacturing technology to continuously mix active pharmaceutical ingredients with excipients for a myriad of traditional and novel dosage forms. Pharmaceutical Extrusion Technology, Second Edition reflects how this has spawned numerous research activities, in addition to hardware and process advancements. It offers new authors, expanded chapters and contains all the extrusion related technical information necessary for the development, manufacturing, and marketing of pharmaceutical dosage forms.Key Features: Reviews how extrusion has become an accepted technology to continuously mix active pharmaceutical ingredients with excipients Focuses on equipment and process technologyTable of ContentsChapter 1: Twin Screw Extruders for Pharmaceutical Products from a Technical and Historical Perspective. Chapter 2: Extruder Design. Chapter 3: Control Strategy Considerations for Continuous Manufacturing using Hot Melt Extrusion. Chapter 4: Twin Screw Extrusion & Screw Design. Chapter 5: Die Design. Chapter 6: Feeding Technology and Material Handling for Pharmaceutical Extrusion. Chapter 7: Rheology, Torque and Oscillatory Rheometers. Chapter 8: Foam Extrusion. Chapter 9: Melt Pelletization and Size Reduction. Chapter 10: Extended Release Dosage Forms. Chapter 11: Shape Extrusion – Extruded Implantable Drug Delivery Devices: Materials, Applications and Processing. Chapter 12: Film, Sheet and Laminates. Chapter 13: Melt Extruded Amorphous Solid Dispersions. Chapter 14: Process Modeling and Simulation of Extrusion Operations. Chapter 15: Devolatilization via Twin Screw Extrusion: Theory, Tips, and Test Results. Chapter 16: Continuous Granulation Methodologies. Chapter 17: Installation, Commissioning & Qualification. Chapter 18: Extruder Control Systems.

    Out of stock

    £171.00

  • Nanotherapeutics

    Taylor & Francis Inc Nanotherapeutics

    1 in stock

    Book SynopsisThe emergence of nanotherapeutics is attributable to the integration of nanotechnology, recombinant DNA technology, and synthetic organic chemistry with medicine for treating critical human diseases in a more efficient and specific molecular approach than therapy with conventionally-designed and formulated drugs. Nanotherapeutics: From Laboratory to Clinic comprehensively discusses the current shortcomings for delivery of classical (small) drugs, macromolecular therapeutics, and recombinant vaccine via the common intravascular and extravascular routes.The book describes the synthetic/chemical engineering methods as well as recombinant, hybridoma, and phage display technologies to fabricate different types of nanoparticulate carriers and drugs. It also reveals the diversified approaches undertaken by harnessing nanotechnology to overcome the multistep extracellular and intracellular barriers and to facilitate the development of novel strategies for therapeutic deTable of ContentsEmergence of nanotherapeutics: Challenges in classical drug transport versus macromolecular drug design. The ultimate destinations for delivery and release of nanotherapeutics. Diversity of bioactive nanoparticles from biological, chemical, and physical perspectives. Fabrication strategies for biofunctional nanoparticles. Interactions and orientation of therapeutic drugs in the vicinity of nanoparticles. Variable interactions of nanoparticles with blood, lymph, and extracellular and intracellular components. Pharmacokinetics and biodistribution of nanoparticles. Specific roles of nanoparticles in various steps of drug transport. Nanotechnology approaches to modulate transport, release, and bioavailability of classical and emerging therapeutics. Nanotechnology in the development of innovative treatment strategies. Nanoparticles for therapeutic delivery in animal models of different cancers. Nanoparticles for therapeutic delivery in animal models of other critical human diseases. Nanomedicine in clinical trials. Approved and commercialized nanomedicine. Current safety issues: Biodegradability, reactivity, and clearance. References.

    1 in stock

    £175.75

  • Marine Glycobiology

    Taylor & Francis Inc Marine Glycobiology

    1 in stock

    Book SynopsisMarine glycobiology is an emerging and exciting area in the field of science and medicine. Glycobiology, the study of the structure and function of carbohydrates and carbohydrate-containing molecules, is fundamental to all biological systems and represents a developing field of science that has made huge advances in the last half-century. This book revolutionizes the concept of marine glycobiology, focusing on the latest principles and applications of marine glycobiology and their relationships.Trade Review"The book describes carbohydrates conjugated with additional molecules – an area that could be called terra incognita, because it has been unexploited until now. An important part of the book constitutes analytical techniques, which are a challenge. Another important aspect is the practical application of those unique compounds: in biomedicine, bio-based technologies. The book contains 6 sections and 38 chapters which thoroughly discuss different aspects of glycoconjugates. The book would be useful for academic research, students, but also for industry, as the inspiration for development of innovative and bioactive products."— Katarzyna Chojnacka, Wroclaw University of Technology, PolandTable of ContentsIntroduction to Marine Glycobiology. Marine Glycoconjugates of Reproduction and Chemical Communications. Marine Glycans. Marine Glycosylation. Marine Glycoproteins. Marine Proteoglycans. Marine Glycolipids. Marine Glycomics. Marine Glycoenzymes. Marine Carbohydrates. Bioinformatics of Glycobiology. Biological Role of Glycoconjugates. Glycoconjugates in Biomedicine and Biotechnology.

    1 in stock

    £171.00

  • BioTargets and Drug Delivery Approaches

    Taylor & Francis Inc BioTargets and Drug Delivery Approaches

    Out of stock

    Book SynopsisThe advances in drug delivery systems over recent years have resulted in a large number of novel delivery systems with the potential to revolutionize the treatment and prevention of diseases. Bio-Targets and Drug Delivery Approaches is an easy-to-read book for students, researchers and pharmaceutical scientists providing a comprehensive introduction to the principles of advanced drug delivery and targeting their current applications and potential future developments.Table of ContentsChapter 1: Basic Concepts in Drug Targeting Chapter 2: Biological Targets: Identification, Selection and ValidationChapter 3: Emerging Therapeutic Targets for DiabetesChapter 4: Prodrug Strategy: An Effective Tool in Drug Delivery and TargetingChapter 5: Drug Targeting Strategies to CNS DisordersChapter 6: Natural Polymers in Colon Targeting: Approaches and Future PerspectivesChapter 7: Lymphatic Drug TargetingChapter 8: New Drug Targets and Drug Delivery Strategies for Various Ocular DisordersChapter 9: Bone Target Drug Delivery SystemsChapter 10: Targeted Drug Delivery in Solid Tumours: An Overview and Novel Approaches for TherapyChapter 11: Mitochondria as an Emerging Target for the Delivery of Small Therapeutic MoleculesChapter 12: Antisense Oligonucleotide-Mediated Target Specific Gene Silencing: Design, Delivery Strategies and Therapeutic ApplicationsChapter 13: Biodegradable Polymeric Carriers for Delivery of siRNAChapter 14: Organic-Inorganic Nanocomposites for Biomedical Applications Chapter 15: Carbon Nanotube Induced Targeted Drug DeliveryChapter 16: Functionalized Cyclodextrin: A Versatile Supramolecular Systems for Drug DeliveryChapter 17: Nanopolymer Scaffolds as Novel Carriers for Cells and DrugsChapter 18: Biotargets for Polyionic Glucan Derivatives and their Nano-Therapeutic SystemsChapter 19: Novel Carriers for Targeted Delivery of Herbal MedicinesChapter 20: Toxicological Concerns Related to Nanoscale Drug Delivery Systems

    Out of stock

    £166.25

  • Industrial Applications of Marine Biopolymers

    Taylor & Francis Inc Industrial Applications of Marine Biopolymers

    1 in stock

    Book SynopsisIndustrial Applications of Marine Biopolymers presents different classes of marine biopolymers and their industrial applications, demonstrating the precious value of ocean resources to society. This timely volume discusses the exceedingly useful polymers derived from these materials that are biodegradable, biocompatible, and at times water soluble. Direct use or chemically modified forms of such biomaterials have many chemical sites, making them suitable for varied types of industrial applications. In addition, this book also addresses current global challenges of conservation, including extended drought conditions and the need for improved agricultural methods, together with new bio-medical developments. It is suitable for anyone who has an interest in the industrial applications of biopolymers.Table of ContentsPart – I Isolation and physicochemical characterization of marine biopolymers. Introduction to marine biopolymers. Isolation of marine biopolymers. Physicochemical characterization of marine biopolymers. Isolation and characterization of chitin and chitosan. Isolation and characterization of alginate from seaweeds. Isolation and characterization of carrageenans and agar / agarose. Influence of physicochemical properties of chitin and chitosan on its potential applications. Structural characteristics of marine biopolymers. Isolation and characterization techniques used for hydroxyapatite. Biosynthesis of marine biopolymers. Electrostatic properties of marine biopolymers. Applications of analytical tools such as NMR, IR and Mass spectrometry to analyse the structural properties of marine biopolymers. Mechanical properties of Marine biopolymers and its derivatives. Use of X-Ray diffraction analysis on Marine biopolymers. Production of marine biopolymers through enzymatics process. Chemical modification of chitin and chitosan for its potential applications. Enzymatic modification of marine biopolymers. Effect of Molecular weight and the degree of deacetylation of chitosan and its determination. Isolation and characterization of hyaluronic acid. Isolation of low-molecular weight biopolymers from marine sources. Physio-chemical characterization of tunicin, laminarin and furcellaran. Isolation and characterization of inorganic biopolymer.Part – II Biological and Biomedical applications of the marine biopolymers Chapter 1: Marine biopolymers for anti-cancer drugs.Chapter 2: Drug Delivery applications of chitin and chitosan.Chapter 3: Gene delivery applications of chitin and chitosan.Chapter 4: Biological activities of Marine biopolymers.Chapter 5: Applications of nano form of biopolymers.Chapter 6: Nanocomposites and nanoparticles of biopolymers in bio-nano-technology.Chapter 7: Antimicrobial activity of marine biopolymers.Chapter 8: Role of Alginate in drug delivery applications.Chapter 9: Application of marine hydroxyapatite scaffolds in bone tissue engineering.Chapter 10: Modified marine polysaccharides and Seaweads in drug delivery applications.Chapter 11: Marine biopolymers as carriers and immunoadjuvants in vaccine delivery.Chapter 12: Antidiabetic activity and anticolestic activity of marine biopolymers.Chapter 13: Antiviral activity of marine biopolymers.Chapter 14: Potential anticoagulant effect of marine derived biopolymers.Chapter 15: Marine biopolymers for antiallergic therapeutics.

    1 in stock

    £175.75

  • Aqueous Polymeric Coatings for Pharmaceutical

    Taylor & Francis Inc Aqueous Polymeric Coatings for Pharmaceutical

    1 in stock

    Book SynopsisAqueous-based film coating has become routine in the pharmaceutical industry. This process eliminates the use of organic solvents and thus avoids economic, environmental, and toxicological issues related to residual solvents and solvent recovery. Aqueous-based coating, however, is complex and many variables may impact the final product and its performance. This fourth edition of Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms aims to provide insight into the factors and parameters that should be considered and controlled for the successful development and commercialization of a coated product. The fourth edition has been revised and expanded to reflect the most recent scientific advancements from the literature. The contributing authors explain in detail, using illustrated examples, appropriate steps to solve and ideally avoid formulation, processing, and stability problems and to achieve an optimized dosage form. Trade names and chemical names of comTable of ContentsAqueous-based polymeric coating. Pseudolatex dispersions for controlled drug delivery. Processing and equipment considerations for aqueous-based coatings. Mechanical properties of polymeric films prepared from aqueous dispersions. Defects in aqueous film coated solid oral dosage form. Adhesion of polymeric films. Influence of insoluble additives on the properties of polymeric coating systems. Process and formulation factors affecting drug release from pellets coated with ethylcellulose pseudolatex Aquacoat. Chemistry and application properties of polymethacrylate systems. Application of HPMC and HPMCAS to aqueous film coating of pharmaceutical dosage forms. The applications of formulated systems for aqueous film coating of pharmaceutical solid oral dosage forms. *Substrate considerations when developing an aqueous film coated solid oral dosage form. Polymer interactions with drugs and excipients. Physical aging of polymers and it effect on the stability of solid oral dosage forms.

    1 in stock

    £166.25

  • Imaging in Photodynamic Therapy

    Taylor & Francis Inc Imaging in Photodynamic Therapy

    15 in stock

    Book SynopsisThis book covers the broad field of cellular, molecular, preclinical, and clinical imaging either associated with or combined with photodynamic therapy (PDT). It showcases how this approach is used clinically for cancer, infections, and diseases characterized by unwanted tissue such as atherosclerosis or blindness. Because the photosensitizers are also fluorescent, the book also addresses various imaging systems such as confocal microscopy and small animal imaging systems, and highlights how they have been used to follow and optimize treatment, and to answer important mechanistic questions. Chapters also discuss how imaging has made important contributions to clinical outcomes in skin, bladder, and brain cancers, as well as in the development of theranostic agents for detection and treatment of disease. This book provides a resource for physicians and research scientists in cell biology, microscopy, optics, molecular imaging, oncology, and drug discovery.Trade Review"The editors have skillfully compiled a wide and comprehensive spectrum from contributors around the world on up-to-date imaging technologies for photodynamic therapy (PDT), with a wealth of clinical images." –Optics & Photonics News"The editors have skillfully compiled a wide and comprehensive spectrum from contributors around the world on up-to-date imaging technologies for photodynamic therapy (PDT), with a wealth of clinical images." –Optics & Photonics NewsTable of ContentsINTRODUCTION. Looking out the optical window: Physical principles and instrumentation of imaging in photodynamic therapy. Photochemistry and photophysics of PDT and photosensitizers. IN VITRO MICROSCOPY FOR PHOTOSENSITIZER LOCALIZATION IN CELLS. Phthalocyanines in photodynamic therapy. Singlet oxygen luminescence imaging: A prospective tool in bioscience? Microbial biofilms and antimicrobial photodynamic therapy. High-content imaging for photosensitizer screening. IN VITRO MICROSCOPY OF CELL DAMAGE AND DEATH PROCESSES AFTER PDT. Enhanced efficacy of photodynamic therapy via an iron–lysosome–mitochondria connection: Studies with phthalocyanine 4. Role of cell death pathways in response to photodynamic therapy in gliomas. In search of specific PDT photosensitizers: Subcellular localization and cell death pathways. THERANOSTIC AGENTS AND NANOTECHNOLOGY. Quantum dots in PDT. Tetrapyrrole-based theranostic combinations of photodynamic action and magnetic resonance imaging. Theranostic applications of photodynamic molecular beacons. Tumor-specific imaging and photodynamic therapy targeting the urokinase receptor. SMALL ANIMAL IMAGING. Vascular imaging in photodynamic therapy. Photosensitizer activity imaging on the microscopic scale. Bioluminescence imaging for monitoring the effectiveness of photodynamic therapy for infections in animal models. CLINICAL IMAGING. Imaging of photosensitizers in skin. Brain tumor imaging with ALA. PDT of non-muscle-invasive bladder cancer with Hexylester Aminolevulinate: Optimization of the illumination wavelengths by fluorescence spectroscopy and imaging. Endoscopic imaging and photodynamic therapy. Spectroscopic imaging in prostate PDT. Fluorescent-guided resection in clinical oncology.

    15 in stock

    £285.00

  • Hydrogels

    Taylor & Francis Inc Hydrogels

    5 in stock

    Book SynopsisHydrogels are crosslinked, macromolecular polymeric materials arranged in a three-dimensional network, which can absorb and retain large amounts of water. Hydrogels are commonly used in clinical practice and experimental medicine for a wide range of applications, including drug delivery, tissue engineering and regenerative medicine, diagnostics, cellular immobilization, separation of biomolecules or cells, and barrier materials to regulate biological adhesions. This book elucidates the underlying concepts and emerging applications of hydrogels and will provide key case studies and critical analysis of the existing research.Table of ContentsMicroarchitecture of Water Confined in Hydrogels. The Fate of Thixotropy in Hydrogels. Hydrogel Network Parameters. Mechanisms of drug release from hydrogels in medical applications. Hydrogel Coatings for Medical Device Applications. Hydrogels for Bone Regeneration: An Overview. Hydrogels in Wound Management. Hydrogels for Imaging, Sensing and Diagnostics. Engineering Hyaluronan (HA) Hydrogels with Bioactive and Mechanical Signals. Hydrogel Nanomaterials for Cancer Diagnosis and Therapy. Thermosensitive Hydrogels for Drug Delivery and Tissue Engineering. Silk Hydrogels for Drug and Cell Delivery. In-Situ Forming Phase-inversion Injectable Hydrogels for Controlled Drug Release. Transdermal Applications of Hydrogels. Preparation of Photocurable Hydrogels. Stimuli-Responsive Biomolecular Hydrogels for Medical Applications. Bioengineering Complexity and Tuneability in Hydrogels. Synthetic hydrogels for 3D cell culture.

    5 in stock

    £199.50

  • Regulatory and Pharmacological Basis of Ayurvedic

    Taylor & Francis Inc Regulatory and Pharmacological Basis of Ayurvedic

    5 in stock

    Book SynopsisRegulatory affairs and pharmacological drug safety issues of Ayurvedic medicine has been overlooked by practitioners for many years. Research in Ayurveda is now a world-wide phenomenon, and several large pharmaceutical corporations are investing money for novel drug discovery from Ayurvedic sources. This book examines the regulatory and pharmacological aspects and includes extensive data on scientific evaluation carried out on Ayurvedic formulations. It will also serve as a reference book on standardization, pre-clinical studies, and clinical and toxicological studies on Ayurvedic formulations.Table of ContentsRegulatory Affairs in Ayurveda. Introduction to Regulatory Affairs. Introduction to Ayurvedic Pharmacopoeia of India. Drug Cosmetic Act and Ayurvedic Drugs. Ayurvedic Drug Manufacturing License. Good Manufacturing Practices for Ayurvedic, Siddha and Unani Medicines (SCHEDULE T). Ayurvedic Drug Industry. Pharmacovigilance of Ayurvedic Drugs. Heavy Metal Content of Ayurvedic Formulations. Genotoxicity of Ayurvedic Formulations. Aristolochic Acid Distribution in Ayurvedic Formulations. Patent and IPR Issues of Ayurvedic Formulations. Ayurvedic Nutraceuticals. Ayurvedic Cosmetics. Pharmacological Investigations on Ayurvedic Formulations. A-Z of Major Ayurvedic Formulations.

    5 in stock

    £166.25

  • Advances in Pulmonary Drug Delivery

    Taylor & Francis Inc Advances in Pulmonary Drug Delivery

    Out of stock

    Book SynopsisThe respiratory tract has been used to deliver biologically active chemicals into the human body for centuries. However, the lungs are complex in their anatomy and physiology, which poses challenges to drug delivery. Inhaled formulations are generally more sophisticated than those for oral and parenteral administration. Pulmonary drug development is therefore a highly specialized area because of its many unique issues and challenges. Rapid progress is being made and offers novel solutions to existing treatment problems. Advances in Pulmonary Drug Delivery highlights the latest developments in this field.Table of ContentsForewordChapter 1: Inhaled proteins and peptides.Chapter 2: Inhaled insulin: More compelling than ever.Chapter 3: Inhaled therapeutic siRNA for the treatment of respiratory diseases.Chapter 4: New molecules to treat asthma and COPD.Chapter 5: Inhaled anti-cancer agents.Chapter 6: Inhaled countermeasures for respiratory tract viruses.Chapter 7: Pulmonary delivery of antibiotics for respiratory infections.Chapter 8: Inhaled liposomes.Chapter 9: Inhaled traditional Chinese medicine for respiratory diseases.Chapter 10: Bronchoprovocation tests for evaluation of drug efficacy in asthma.

    Out of stock

    £166.25

  • Analyzing Longitudinal Clinical Trial Data

    Taylor & Francis Inc Analyzing Longitudinal Clinical Trial Data

    1 in stock

    Book SynopsisAnalyzing Longitudinal Clinical Trial Data: A Practical Guide provides practical and easy to implement approaches for bringing the latest theory on analysis of longitudinal clinical trial data into routine practice.The book, with its example-oriented approach that includes numerous SAS and R code fragments, is an essential resource for statisticians and graduate students specializing in medical research. The authors provide clear descriptions of the relevant statistical theory and illustrate practical considerations for modeling longitudinal data. Topics covered include choice of endpoint and statistical test; modeling means and the correlations between repeated measurements; accounting for covariates; modeling categorical data; model verification; methods for incomplete (missing) data that includes the latest developments in sensitivity analyses, along with approaches for and issues in choosing estimands; and means for preventing missing data. Each chapter sTrade Review"This book deals mostly with longitudinal clinical trial data, but also with the related issue of imputing missing data. The book is an excellent resource overall, as it is fairly comprehensive, well referenced, and clear."~Vance W. Berger, PhD, NIH/NCI/DCP/BRGAnalyzing Longitudinal Clinical Trial Data provides, in a well organized and small format, a fairly easy read that could be helpful for both researchers analyzing longitudinal data collected from clinical trials (or perhaps even observational studies) and instructors teaching undergraduate and graduate courses on clinical trials, longitudinal data, and missing data. The book is divided into four well-structured and complementary sections: background and setting, general modeling strategies and methods, methods for dealing with missing data, and overall guidance (with illustration) for developing a study.~Journal of the American Statistical Association "I recommend this book to anyone who deals with longitudinal clinical trials data at any level with confidence as it concisely presents essential ideas and analysis techniques with illustrative examples, in an intuitively appealing way, both on analytic and conceptual levels. It addresses an important need for practicing (bio)statisticians."~Biometrical JournalTable of ContentsBackground and Setting. Introduction. Objectives and estimands–determining what to estimate. Study design–collecting the intended data. Example data. Mixed effects models review. Modeling the observed data. Choice of dependent variable and statistical test. modeling covariance (correlation). Modeling means over time. Accounting for covariates. Categorical data. Model checking and verification. Methods for dealing with missing Data. Overview of missing data. Simple and ad hoc Approaches for dealing with missing data. Direct maximum likelihood. Multiple imputation. Inverse probability. Methods for incomplete categorical data weighted generalized estimated equations. Doubly robust methods. MNAR methods. Methods for incomplete categorical data. A comprehensive approach to study development and analyses. Developing statistical analysis plans. Example analyses of clinical trial data.

    1 in stock

    £82.64

  • Mathematical and Statistical Skills in the

    Taylor & Francis Inc Mathematical and Statistical Skills in the

    Out of stock

    Book SynopsisMathematical and Statistical Skills in the Biopharmaceutical Industry: A Pragmatic Approach describes a philosophy of efficient problem solving showcased using examples pertinent to the biostatistics function in clinical drug development. It was written to share a quintessence of the authors' experiences acquired during many years of relevant work in the biopharmaceutical industry. The book will be useful will be useful for biopharmaceutical industry statisticians at different seniority levels and for graduate students who consider a biostatistics-related career in this industry.Features: Describes a system of principles for pragmatic problem solving in clinical drug development. Discusses differences in the work of a biostatistician in small pharma and big pharma. Explains the importance/relevance of statistical programming and data management for biostatistics and necessity for integration on various levels. DescTrade Review"This is a highly original, extremely interesting, and in many ways impressive book. Its matter is largely about what it entails to be a professional biostatistician (in the widest sense of the word): what skills and attitudes you need to solve the problems encountered in exercising your profession. It is clear that the authors have thought long and hard about the problems they present. The case-studies are real, complex, interesting, and instructive. The book could only have been written by skilled scientists with long experience of working in the pharmaceutical industry. The reader benefits from the authors’ experience. The reader can be in no doubt that he or she is in the hands of experts. I learned a lot from the book." ~Stephen Senn, Retired, Honorary Professor, University of Sheffield " . . . the book is extremely well written in an accessible and entertaining style, while being informative at the same time. It can wholeheartedly be recommended to every early career biostatistician and PhD student in (bio)statistics, who is considering going into pharmaceutical research, or conducting research in clinical trials." ~Diane Uschner, ISCB News "The book is based on the author’s cumulative experience in the biopharmaceutical industry and wisdom gained from a myriad of challenging problems. Further, given the diverse set of covered topics, we feel that this book would benefit those new to the industry (e.g., graduate students), as well as experienced professionals. Through detailed case studies, the book covers the broad skill set that is needed in the biopharmaceutical industry. Covered clinical drug development topics include: the early stage (e.g., pharmacology, toxicology, pharmacokinetics), the late stage (e.g., trial management and analysis, investigational new drug or new drug applications, communications with regulatory), strategic planning, the functional role of biostatisticians within a biopharmaceutical company, and the many functional roles that a biostatistician must interact with. "The whole reading journey turned out to be a pleasant and educational one…For readers who are interested or are already in the biopharmaceutical industry, this book can provide a framework that helps you build a successful career in this dynamic and exciting industry." ~American Statistician Table of ContentsAnswers to Inevitable Questions. A Road to an Integral Approach: Atlas and Caryatid of Biostatistics. Atlas–Statistical Programming. Caryatid–Data Management. Further Down the Road: Where and How We Live–Tactical Aspects. Environment: Biostatistics in the Regulatory Science Setting. Toolkit: Pharmacometrics. Broadening the View: Making Life Interesting–Strategic Aspects. Environment Enhancement: Teaching Statistical Concepts to Medical Colleagues. Where Should We Go?–Portfolio Optimization– and How Can We Do It Faster?–Adaptive Clinical Development Strategies. What Are We Measuring? And How Should We Do This?–Development of New Validated Scoring Systems. Can We Survive Mistakes?–Resurrecting a Failed Clinical Program. Can We Predict Unpredictable?–Planning the Timelines of Real-Life Open-Ended Projects.

    Out of stock

    £99.75

  • Data Integrity in Pharmaceutical and Medical

    Taylor & Francis Inc Data Integrity in Pharmaceutical and Medical

    Out of stock

    Book SynopsisData integrity is fundamental in a pharmaceutical and medical devices quality system. This book provides practical information to enable compliance with data integrity, while highlighting and efficiently integrating worldwide regulation into the subject. The ideas presented in this book are based on many years' experience in regulated industries in various computer systems development, maintenance, and quality functions. In addition to case studies, a practical approach will be presented to increase efficiency and to ensure that the design and testing of the data integrity controls are correctly achieved.Table of ContentsPreface. Introduction. Inspection Trends. Electronic Records Life Cycle. MHRA Definitions. Electronic Records Governance. Relevant Electronic Records Management Procedural Controls. Electronic Records Controls - Supporting Processes. Electronic Records Controls - In Storage. Electronic Records Controls - During Processing. Electronic Records Controls - While in Transit. Trustworthy Computer Systems. Electronic Records and Service Providers. Relevant Worldwide GMP Regulations and Guidelines. MHRA Guidance. Electronic Records Management - 21 CFR Part 211. Electronic Records Management - EMA Annex 11. Self Inspection. Summary. Appendices: Glossary of Terms. Abbreviations and Acronyms. Regulatory Cross Match. MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015. Relevant Worldwide GCP and GLP Regulations and Guidelines. Electronic Records Integrity in Non-Clinical Laboratories. Electronic Records Integrity in Clinical Systems. Electronic Integrity in a Data Warehouse and Business Intelligence.

    Out of stock

    £121.50

  • Data and Safety Monitoring Committees in Clinical

    Taylor & Francis Inc Data and Safety Monitoring Committees in Clinical

    1 in stock

    Book SynopsisPraise for the first edition:Given the author's years of experience as a statistician and as a founder of the first DMC in pharmaceutical industry trials, I highly recommend this booknot only for experts because of its cogent and organized presentation, but more importantly for young investigators who are seeking information about the logistical and philosophical aspects of a DMC. -S. T. Ounpraseuth, The American Statistician In the first edition of this well-regarded book, the author provided a groundbreaking and definitive guide to best practices in pharmaceutical industry data monitoring committees (DMCs). Maintaining all the material from the first edition and adding substantial new material, Data and Safety Monitoring Committees in Clinical Trials, Second Edition is ideal for training professionals to serve on their first DMC as well as for experienced clinical and biostatistical DMC members, sponsor and regTrade Review "The book by Dr. Herson is written amazingly well. The book concentrates on pharmaceutical industrysponsored confirmatory clinical trials and can serve as excellent sources of knowledge for all the aspects of data safety monitoring committee (DMC) activities. A great feature of the book is the “DMCounselor” section at the end of each chapter, covering nearly 70 questions with answers, of which about 33% are for a DMC Chair, 30% for the DMC Biostatistician member, 30% for a DMC physician member, and the rest are for others (e.g., project manager)."~ Daniel Jia, Journal of Biopharmaceutical Statistics"Nicely written and readable cover-to-cover, the author walks through every facet of a Data Monitoring Committee (DMC) beginning with an overview of their past and current place in drug development, to how they are organized and interfaced with other committees, and on to the specifics of how a typical meeting is split into an open and closed session. From there it moves on to clinical issues, including how SAEs are categorized, statistical methods, including Bayesian and frequentist conditional power calculations, common biases and pitfalls, and guidance for how DMC decisions are made. It concludes with emerging issues due to new clinical trial designs mandated by the FDA to speed up the drug development process."~Donna Pauler Ankerst, BiometricsTable of ContentsPreface to the Second Edition. Introduction. Organization of a Safety Monitoring Program for a Confirmatory Trial. Meetings. Clinical Issues. Statistical Issues. Biases and Pitfalls. DMC Decisions. Emerging issues. Appendix.

    1 in stock

    £104.50

  • Organic and Medicinal Chemistry: Volume 2

    Nova Science Publishers Inc Organic and Medicinal Chemistry: Volume 2

    1 in stock

    Book Synopsis

    1 in stock

    £163.19

  • Recent Advances in Computer Aided Drug Designing

    Nova Science Publishers Inc Recent Advances in Computer Aided Drug Designing

    Out of stock

    Book SynopsisWe are extremely happy to introduce our new book, Recent Advances in Computer Aided Drug Designing. While interacting with many researchers in the field of biotechnology and allied sciences, we felt that there was need for a book that could easily bridge the gap between in silico methods applied in structural bioinformatics for drug designing and wet lab workers. Today, when computational skills in biology and biomedical research are in high demand, this book presents updated content for methods and tools applicable in modern computer-aided drug designing. Researchers are pouring knowledge into databases that are publicly available and laboratories across the globe are accessing this information for analysis and further investigation. There is a battery of data scientists involved in development and maintenance of online databases. Alongside them, there is another class of programmers and scientists involved in development of software tools for analysis of this data. Modern tools based on machine learning are available to provide accuracy and efficiency with speedy analysis of biological and biomedical data. In many cases, analysis of readily available biological data helps to decide future directions for laboratory work. Indications obtained from such analytics save time and resources which could be very crucial in general. Publicly available protein three-dimensional structure and drug databank libraries have facilitated the drug discovery process. Millions of drugs can be screened in a few hours by using virtual screening tools. Molecular viewing tools can be used to visualize macromolecules and their interactions with drugs. Findings from such studies are being used to validate results directly in laboratories. Efforts have been made to cover all areas relevant for computer-aided drug designing to allow this book to serve as a standard reference book and meet the requirements of graduate students and researchers working in drug design and structural bioinformatics. Some chapters are dedicated to basic concepts in computer-aided drug discovery while other chapters present applications of the available tools in the field. Contents from exemplary method-based chapters are easy to follow and will help new researchers in applying contemporary tools for their studies. The book will also stimulate programmers and data scientists interested in developing tools for structural bioinformatics applications to develop new and improved versions of software. Chapters presenting the basic concepts of methods involved in drug design will help new learners in the field to meet the challenges of designing novel therapeutics by using computational tools. Cross-disciplinary research is in trend nowadays and such investigations involving experts of their respective fields are highly promising and fruitful. Drug discovery requires experts from health sciences and medical sciences, molecular biologists, bioinformaticians, biotechnologists, biochemists, statisticians, biophysicists and clinicians. For a complete piece of translated product such as a drug, inputs from specialist researchers are needed. Modern rational drug discovery approaches are truly inter-disciplinary fields which require a systems biology approach for successful ventures. This book covers all steps of drug design, from drug target identification to intermediate steps to successful clinical trials, making it truly essential for modern researchers in the drug discovery and structural bioinformatics fields.Table of ContentsFor more information visit: https://novapublishers.com/shop/recent-advances-in-computer-aided-drug-designing/

    Out of stock

    £163.19

  • Pharmacokinetic Analysis: A Practical Approach

    Technomic Publishing Co ,U.S. Pharmacokinetic Analysis: A Practical Approach

    1 in stock

    Book SynopsisThis insightful work provides a useful introduction to the very large and important field of pharmacokinetics. The authors have selected the Time Constant Approach as a unifying view within which to present important application areas. In addition to providing consistency, their approach provides the novice with an intuitive time view that is meaningful from the outset. This approach allows one to get a "feel" for the data and to relate it to other data in a direct and accessible manner.The Time Constant Approach provides a synthesis of the noncompartmental and compartmental methods, with the advantages of both. It starts by defining a physiologically meaningful model based on the pharmacokinetic processes involved. The Time Constant Approach recognizes pharmacokinetics as a number of processes that move drugs between physiological compartments, each process occurring at its own characteristic length of time, to correlate descriptive pharmacokinetic events with time constants of pharmacokinetic processes. While analogous to the three most common testing approaches for pharmacokinetics (the noncompartmental, compartmental and statistical moment approaches) the Time Constant Approach possesses many advantages.

    1 in stock

    £275.50

  • Clin-Alert 2000

    Taylor & Francis Inc Clin-Alert 2000

    1 in stock

    Book SynopsisComplete, Authoritative, Unrivaled CollectionClin-Alert, long established as the pre-eminent source of adverse drug reaction/interaction, now brings you Clin-Alert 2000. Presented in a quick reference format, Clin-Alert 2000 allows very easy access by drug class for comparison reports. Pharmacological classes are arranged based on a modified AHFS Therapeutic Classification Code System AND include the addition of a comprehensive section on alternative/herbal medicines.Table of ContentsDrug Classes Include: Alternative Therapies (herbals, supplements). Antihistamines. Anti-infective Agents. Anti-neoplastics. Autonomic Drugs. Blood Formation and Coagulation. Cardiovascular Drugs. CNS Agents (Analgesics, Sedatives, Psychotherapeutics). Dental Agents. Diagnostic Agents. Electrolytic and Water Balance. EENT Preparations. Gastrointestinal Agents. Hormones and Contraceptives. Radioactive Agents. Topical Products. Vaccines. Vitamins. Miscellaneous.

    1 in stock

    £194.75

  • Biochips as Pathways to Drug Discovery

    Taylor & Francis Inc Biochips as Pathways to Drug Discovery

    1 in stock

    Book SynopsisIn the fiercely competitive pharmaceutical marketplace, your organization cannot afford to spend excess dollars developing drugs that will fail to get FDA approval or have profoundly poor characteristics. Biochips as Pathways to Drug Discovery takes a comprehensive look at how the industry faces these challenges, using new technologies such as biochips to reduce the cost of drug discovery and improve drug safety. The book explores the tools and skills required at each step of the discovery process when using biochips to determine biological outcomes.The authors provide an in-depth review of the clinical and pharmacogenomic relevance of biochips, ChIP-chip assays, and high-throughput approaches. They discuss how biochips are used to develop biomarkers in the drug discovery process, primarily for gene expression profiling and Single Nucleotide Polymorphism (SNP) analysis. The book includes coverage of experimental theory, quality control, clinical laboratory sampling considerations, database concepts, industrial laboratory design, and the analysis of the resultant large data sets. It discusses the application of biochips to the study of malaria, toxicogenomics, and SNPs, as well as intellectual property and market overviews. The book concludes with a comprehensive overview of how these chips are employed from early target discovery through preclinical toxicology and on through to pharmacogenomic and proof of concept studies in humans. Written in an easily accessible style, the breadth of coverage introduces the subject to those new to the field, while the depth of coverage forms a foundation for future work. The book gives you the knowledge required to leverage the technology into bona fide discoveries. Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.Trade Review“The authors of this volume provide an in-depth review of the clinical and pharmacogenomic relevance of biochips, ChIP-chip assays, and high-throughput approaches. … The book includes coverage of experimental theory, quality control, clinical laboratory sampling considerations, database concepts, industrial laboratory design, and the analysis of the resultant large data sets. … Written in an easily accessible style, the breadth of coverage introduces the subject to those new to the field, while the depth of coverage forms a foundation for future work.” — In Anticancer Research, Vol. 27, No. 3B, May/June 2007"This book is a must have for students who use biochips in their graduate work or others initiating efforts in these areas . . . In summary, Biochips as Pathways to Drug Discovery provides a broad yet detailed look at the use of DNA microarrays in drug discovery." – Matthew D. Disney, The University at Buffalo, The State University of New York, in ChemMedChem, 2008, No. 3Table of ContentsDNA Biochips — Past, Present, and Future: An Overview. Three-Dimensional HydroArrays: Novel Microarrays for Genomic and Proteomic Studies. Biochip in Malaria for Antiparasitic Discovery. Regional Variations in Intestinal ATP-Binding Cassette Transporter Expression Identified with a Global Error Assessment Model. Toxicogenomics in Drug Safety Evaluation: Bridging Drug Discovery and Development. The Next Generation of Automated Microarray Platforms for a Multiplexed CYP2D6 Assay. Biopsy and RNA Extraction Procedures of Muscle and Adipose Tissue for Microarray Gene-Expression Profiling. ChIP-on-Chip: Analysis of Genomewide Protein Binding and Posttranslational Modifications. DNA Microarrays as Functional Genomics Tools for Cancer Drug Discovery. High-Throughput Microarray Analysis. Laboratory Automation: Strategies for High-Volume Industrial Microarray Programs. Association Studies: Practical and Theoretical Considerations for Drug Discovery, Evaluation, and Beyond. Approaches for Microarray Data Validation. Microarray Enterprise Information Management: What Is It and Why Is It Important? Quality Control of Microarray Data. Microarray Data Normalization and Transformation. Amplification Strategies and DNA Biochips. Ribo-SPIA™, a Rapid Isothermal RNA Amplification Method for Gene Expression Analysis. Genomics, Transcriptomics, and Proteomics: Novel Detection Technologies and Drug Discovery. Intellectual Property Issues for DNA Chips and Microarrays. Biochips: Market Drivers and Commercial Prospect. A Pharmaceutical Perspective for Microarrays and Biochips: Current-Market Overview and Future Trends.

    1 in stock

    £54.14

  • Introduction to Statistical Methods for Clinical

    Taylor & Francis Inc Introduction to Statistical Methods for Clinical

    2 in stock

    Book SynopsisClinical trials have become essential research tools for evaluating the benefits and risks of new interventions for the treatment and prevention of diseases, from cardiovascular disease to cancer to AIDS. Based on the authors’ collective experiences in this field, Introduction to Statistical Methods for Clinical Trials presents various statistical topics relevant to the design, monitoring, and analysis of a clinical trial.After reviewing the history, ethics, protocol, and regulatory issues of clinical trials, the book provides guidelines for formulating primary and secondary questions and translating clinical questions into statistical ones. It examines designs used in clinical trials, presents methods for determining sample size, and introduces constrained randomization procedures. The authors also discuss how various types of data must be collected to answer key questions in a trial. In addition, they explore common analysis methods, describe statistical methods that determine what an emerging trend represents, and present issues that arise in the analysis of data. The book concludes with suggestions for reporting trial results that are consistent with universal guidelines recommended by medical journals. Developed from a course taught at the University of Wisconsin for the past 25 years, this textbook provides a solid understanding of the statistical approaches used in the design, conduct, and analysis of clinical trials.Trade Review… There is much good material in this book. The individual chapters are well written and cover the technical aspects as well. A major strength is the ordering of topics to follow the thought process used in the development and implementation of a protocol from defining the question to reporting results. There are careful discussions on fundamental principles and the pivotal role played by statistics is well brought out. … there is much that practicing pharmaceutical statisticians will find useful in this book. They will find the coverage of fundamental principles useful and the technical content of the book a good reference source. …—Pharmaceutical Statistics, 2010… fits the need for a contemporary text and handbook that is oriented toward the clinical trial statistician. I highly recommend it and look forward to using it as both a primary and supplemental text in our curriculum, as well as a research resource.—James J. Dignam, University of Chicago, JASA, March 2009The (technical) statistical content is the main focus of the book and this is what helps it to stand apart from most others on clinical trials (even the more obviously statistically orientated ones). It takes the reader to quite a technical background that would serve him or her well if moving on to research problems in the various areas covered, yet does not lose sight of practical issues. … For those of us with the interest (and need) to grapple with these more statistical issues, I wholeheartedly recommend it.—Biometrics, December 2008…The book is very well written and clear. … the authors generally strike the right balance for the intended audience. The inclusion of many historically important as well as contemporary examples to illustrate various points throughout the text is a major strength, as is the inclusion of several modern topics not seen in other texts. As a basis for a course in clinical trials for graduate students in biostatistics, this book is outstanding. In addition, statisticians in the pharmaceutical industry, government, or academia … will find this text extremely informative and useful.” —Michael P. McDermott, University of Rochester Medical Center, Journal of Biopharmaceutical Statistics, 2008Table of ContentsPreface. Introduction to Clinical Trials. Defining the Question. Study Design. Sample Size. Randomization. Data Collection and Quality Control. Survival Analysis. Longitudinal Data. Quality of Life. Data Monitoring and Interim Analysis. Selected Issues in the Analysis. Closeout and Reporting. Special Topics. Appendix. References. Index.

    2 in stock

    £80.74

  • Laboratory Manual for Clinical Veterinary

    Teton NewMedia Laboratory Manual for Clinical Veterinary

    5 in stock

    Book SynopsisVeterinary students and practicing technicians will find this book to be an important bench manual as well as an educated tool to have on their desk. Also included in the package is a free online resource for testing and additional information.Table of Contents1. THE CLINICAL PATHOLOGY LABORATORY 2. THE CLINICAL PATHOLOGY LABORATORY 3. URINALYSIS LABORATORY 4. PROPER LABORATORY TREATMENT OF BLOOD SMEARS AND CELLS 5. HEMATOLOGY- THE BLOOD SMEAR 6. HEMATOLOGY - THE WHITE BLOOD CELL COUNT AND IDENTIFICATION 7. THE 3-H’S OF HEMATOLOGY 8. COAGULATION TESTING 9. MECHANICAL HEMATOLOGY 10. ANTIGEN-ANTIBODY TESTING 11. COPROPHOLOGICAL TESTING OF GASTROINTESTINAL FUNCTION 12. MICROBIOLOGICAL PREPARATION 13. MICROBIOLOGICAL SUPPLIES AND COLLECTION OF VETERINARY SPECIMENS 14. MICROBIAL CULTURE AND SENSITIVITY AND BIOCHEMICAL TESTING 15. MILK TESTING 16. INTRODUCTION TO CYTOLOGY 17. CYTOLOGY: THE ART OF FINE NEEDLE ASPIRATION 18. NECROPSY: A TECHNICIAN’S ROLE 19. AVIAN, EXOTIC MAMMALS, REPTILES AND FISH 20. RUMEN FLUID COLLECTION AND EVALUATION

    5 in stock

    £54.14

  • Drug Design Research Perspectives

    Nova Science Publishers Inc Drug Design Research Perspectives

    1 in stock

    Book SynopsisDrug design is the approach of finding drugs by design, based on their biological targets. Typically a drug target is a key molecule involved in a particular metabolic or signalling pathway that is specific to a disease condition or pathology, or to the infectivity or survival of a microbial pathogen. Some approaches attempt to stop the functioning of the pathway in the diseased state by causing a key molecule to stop functioning. Drugs may be designed that bind to the active region and inhibit this key molecule. However these drugs would also have to be designed in such a way as not to affect any other important molecules that may be similar in appearance to the key molecules. Sequence homologies are often used to identify such risks. Other approaches may be to enhance the normal pathway by promoting specific molecules in the normal pathways that may have been affected in the diseased state. The structure of the drug molecule that can specifically interact with the biomolecules can be modelled using computational tools. These tools can allow a drug molecule to be constructed within the biomolecule using knowledge of its structure and the nature of its active site. Construction of the drug molecule can be made inside out or outside in depending on whether the core or the R-groups are chosen first. However many of these approaches are plagued by the practical problems of chemical synthesis. Newer approaches have also suggested the use of drug molecules that are large and proteinaceous in nature rather than as small molecules. There have also been suggestions to make these using mRNA. Gene silencing may also have therapeutical applications. This book presents leading-edge research from around the world.

    1 in stock

    £176.24

  • Handbook of Research on Medicinal Chemistry:

    Apple Academic Press Inc. Handbook of Research on Medicinal Chemistry:

    1 in stock

    Book SynopsisThis valuable new book, Handbook of Research on Medicinal Chemistry: Innovations and Methodologies, presents some of the latest advancements in the various fields of combinatorial chemistry, drug discovery, biochemical aspects, pharmacology of medicinal agents, current practical problems, and nutraceuticals. The editors keep the drug molecule as the central component of the volume and aim to explain the associated features essential to exhibiting pharmacological activity. With a unique combination of chapters in biology, clinical aspects, biochemistry, synthetic chemistry, medicine and technology, the volume provides broad exposure to the essential aspect of pharmaceuticals. The volume many important aspects of medicinal chemistry, including techniques in drug discovery pharmacological aspects of natural products chemical mediators: druggable targets advances in medicinal chemistry The field of medicinal chemistry is growing at an unprecedented pace, and this volume takes an interdisciplinary approach, covering a range of new research and new practices in the field. The volume takes into account the latest therapeutic guidelines put forward by the World Health Organization and the U.S Food and Drug Administration..Topics include: drug design drug discovery natural products and supplements and nutraceuticals pharmaceutical approaches to sexual dysfunction drug resistance parasites new natural compounds and identification of new targets stereochemistry aspects in medicinal chemistry common drug interactions in daily practices Handbook of Research on Medicinal Chemistry: Innovations and Methodologies will be a valuable addition to the bookshelves of pharmaceutical scientists and faculty as well as for industry professionals.Trade Review"A valuable book that will deliver newer aspects and applications in the field of medicinal chemistry. . . . A very useful reference book that encompasses various principles and applications associated with medicinal chemistry. [It] integrates insights regarding drug discovery, pharmacological aspects of natural products, druggable targets of chemical mediators, and several classes of medicinal agents. . . . It is a good skillful blend of medicinal chemistry, chemical biology, chemical synthesis, pharmacology, formulation, and miscellaneous subjects."—From the Foreword by Vivekananda Mandal, PhD, Former WERC Researcher, Government of Japan; Institute of Pharmaceutical Sciences, Guru Ghasidas University (Central University), India“An excellent resource for cultivating sound research acumen in the area of medicinal chemistry. Unlike most books in the field, this goes beyond purely theoretical knowledge and greatly focuses on experimental procedures and practical approaches to develop a nuance understanding in the field of drug discovery. I thoroughly enjoyed the clear and interesting presentation of the material. Great efforts have been invested to ensure that it is easily accessible to both students and teachers. The book shows promising potential in exploring the field of medicinal chemistry and will prove to be an important aid to the researchers.”—Neelam Singla, PhD, Director, Accura Research Chemicals Pvt. Ltd., Hyderabad, India"A valuable book that will deliver newer aspects and applications in the field of medicinal chemistry. . . . A very useful reference book that encompasses various principles and applications associated with medicinal chemistry. [It] integrates insights regarding drug discovery, pharmacological aspects of natural products, druggable targets of chemical mediators, and several classes of medicinal agents. . . . It is a good skillful blend of medicinal chemistry, chemical biology, chemical synthesis, pharmacology, formulation, and miscellaneous subjects."—From the Foreword by Vivekananda Mandal, PhD, Former WERC Researcher, Government of Japan; Institute of Pharmaceutical Sciences, Guru Ghasidas University (Central University), IndiaTable of ContentsCombinatorial Chemistry: Role in Lead Discovery. Advanced Techniques in Bimolecular Simulations. Retrometabolic Drug Design. Insight Into The Pharmacological Potentials of Camellia sinensis Linn. Pharmaceutical Importance of Natural Aphrodisiac Drugs. Serotonin: Chemical, Biological and Therapeutic Aspects. Eicosanoids: Constitution and Pathophysiological Functions. Development of Antimalarial Drug Analogues to Combat Plasmodium Resistance. Chemistry and Pharmacology of Β-Lactam Analogues. General Anaesthetics. Stereochemical Aspects in Medicinal Chemistry. Pharmaceutical Interactions in Drug Practices.

    1 in stock

    £139.50

  • Lipase: An Industrial Enzyme Through Metagenomics

    Apple Academic Press Inc. Lipase: An Industrial Enzyme Through Metagenomics

    1 in stock

    Book SynopsisMicrobial lipases are industrially important and have gained attention due to their stability, selectivity, and broad substrate specificity. Lipases are used as medicine, and they also aid in indigestion, heartburn, allergy to gluten in wheat products (celiac disease), Crohn’s disease, and cystic fibrosis. This volume considers the industrial demand for new sources of lipases with different catalytic characteristics that stimulate the isolation, growth, and development of new microbial strains. The volume narrates the challenging metagenomic approach with the isolation of the lipase gene, its cloning into Escherichia coli, culture of the recombinant bacteria, and extraction and assessment of the lipase enzyme. Lipase-producing bacteria are available in different habitats, such as industrial wastes, vegetable oil processing factories, dairy plants, and soils contaminated with oil and oil seeds, among others. This volume is the effort of the authors to document the scientific findings carried out over the last eight years in the area of un-culturable soil microorganisms. The book presents the physic-chemical features of lipases and their specific applications in different commercial industries. The in-depth study looks at metagenomics for lipases from all angles and provides a truly informative resource. It describes the biochemical characterization of lipase enzymes with the high activity in the presence of 1% tributyrin. A wide review has been presented in the book on lipase enzymes purified from a large collection of microbes present in soil, seawater, waste-dumping sites, animal systems (including human beings), and the atmosphere. Stability of enzymes over changing environments of the industry is indeed a big issue, and the book deals at length with the changing temperatures and pH and metal ion concentrations. Table of ContentsIntroduction. Application of Lipases. Metagenomics and Unculturable Bacteria. Accessing Metagenomics. Metagenomics for Lipase. Functional Approach for Metagenomic Library Construction. Overexpression of Recombinant Protein. Biochemical Characterization of Purified Lipase. Genomic Study of Culture Dependent Bacteria. Genomic Study of Culturable Bacteria. Microbial Assay of Culture Supernatant Containing Crude Lipase. Critical Observations.

    1 in stock

    £104.40

  • Dendrimers for Drug Delivery

    Apple Academic Press Inc. Dendrimers for Drug Delivery

    5 in stock

    Book SynopsisWith chapters from highly skilled, experienced, and renowned scientists and researchers from around the globe, Dendrimers for Drug Delivery provides an abundance of information on dendrimers and their applications in the field of drug delivery.The volume begins with an introduction to dendrimers, summarizing dendrimer applications and the striking features of dendrimers. It goes on to present the details of usual properties, structure, classification, and methods of synthesis, with relevant examples. The toxicity of dendrimers is also discussed. The chapter authors provide an exhaustive amount of information about dendrimers and their biomedical applications, including biocompatibility and toxicity aspects, a very useful feature. This informative volume will be valuable resource that will help readers to create products derived from dendrimers and navigate through the regulatory, manufacturing, and quality control hurdles. It will be an important resource for researchers, scientists, upper-level students, and industry professionals. Table of ContentsDendrimers: Branched Nanoarchitectures and Drug Delivery. Dendrimers: A Tool for Advanced Drug Delivery. Dendrimers: General Features and Applications. Computational Approach to Elucidate Dendrimers. An Overview of Dendrimers and Their Biomedical Applications. Dendrimers for Controlled Release Drug Delivery. Dendrimers in Targeted Drug Delivery. Dendrimers in Oral Drug Delivery. Dendrimers in Gene Delivery. Dendrimers as Nanocarriers for Anticancer Drugs. Dendrimeric Architecture for Effective Antimicrobial Therapy.

    5 in stock

    £117.90

  • Nanoconjugate Nanocarriers for Drug Delivery

    Apple Academic Press Inc. Nanoconjugate Nanocarriers for Drug Delivery

    5 in stock

    Book SynopsisThis new volume presents a plethora of new research on the use of nanoconjugate nanocarriers in drug delivery. Nanotechnology as drug carriers has been observed to increase the level of sophistication through a variety of ways. It helps to alleviate some of the pitfalls of conventional dosage forms, such as few pitfalls such as non-specific drug delivery, dose dumping, poor patient compliance, toxicities linked with higher doses, etc.With chapters from highly skilled, experienced, and renowned scientists and researchers, Nanoconjugate Nanocarriers for Drug Delivery is divided into four sections, providing an introduction to nanocarriers for drug delivery, physicochemical features of nanocarriers, and specific applications dealing with drug delivery in particular. The materials used as well as formulation and characterization have been discussed in detail. The nanocarriers covered in the book include nanoparticles, vesicular carriers, carriers having carbon as the core constituent, dispersed systems, etc. The book also delves into the interaction and associations between drug delivery research and its therapeutic applications in practice.The book integrates a wide variety of case studies, research, and theories in an attempt to reveal the diversity and capture the novel approaches of nanoconjugate nanocarriers for drug delivery employed by developers and content experts in the field. This timely publication will be an essential reference and current awareness source, building on the available literature in the field of pharmacy and biomedical science, while also providing ideas for further research opportunities in this dynamic field.Table of ContentsNanobiomaterials for Drug Delivery. Role of Surfactants in Nanotechnology-Based Drug Delivery. Smart Polymeric Nanocarriers for Drug Delivery. Gold Nanoconjugates for Smart Drug Delivery and Targeting. Vesicular Drug Carriers as Delivery Systems. siRNA Delivery with Liposomes as Platform Technology. Theranostic Application of Indocyanine Green Liposomes. Aquasomes: A Nanocarrier System. Quantum Dots for Drug Delivery. Graphene and Graphene-Based Materials: Synthesis, Characterization, Toxicity, and Biomedical Applications. Graphene for Drug Delivery: Focus on Antimicrobial Activity. Carbon Nanotubes for Drug Delivery. Nanoemulsion for Drug Delivery. Nanoconjugate Nanocarriers for Drug Delivery in Tropical Medicine. Nanocarrier-Assisted Drug Delivery for Neglected Tropical Diseases. Self-Assembly of Sucrose and Trehalose Alkyl Ethers into Nanoparticles and Nanorods under Aqueous Conditions.

    5 in stock

    £124.45

  • Natural Polymers for Pharmaceutical Applications:

    Apple Academic Press Inc. Natural Polymers for Pharmaceutical Applications:

    5 in stock

    Book SynopsisThis new volume, Natural Polymers for Pharmaceutical Applications, Volume 1: Plant-Derived Polymers, presents some of the latest research on the applications of natural polymers in drug delivery and therapeutics for healthcare benefits. Polymers and their applications from several plants are discussed in depth, including tamarind gum, gum Arabic, natural carbohydrate polymer gum tragacanth, pectin, guar gum and its derivatives, locust bean gum, sterculia gum, okra gum, and others. The use of the polymers derived from plants as potential pharmaceutical excipients is expanding day by day because of their stability in the biological system, drug-releasing capability, drug-targeting abilities, as well as their bioavailability. Trade Review“A well-engrossed concept on application of natural plant derivatives as pharmaceutical additives. . . . The superlative collection on the application of plant derivatives in design of novel drug delivery systems, such as micro and nanoparticles, throws an insight on the useful applications of plant-derived products. I would say with a definite certitude that the book will prove to be an exemplary reference for academicians and scientist working in the field of plant-derived products for pharmaceutical applications.” - Dr. Tahir Ansari, Assistant Professor, University of Kualalumpur, MalaysiaTable of ContentsVolume 1: Plant-Derived Polymers 1. Pharmaceutical Applications of Tamarind Gum 2. Pharmaceutical Applications of Gum Arabic 3. Recent Advances in Pharmaceutical Applications of Natural Carbohydrate Polymer Gum Tragacanth 4. Application Potential of Pectin in Drug Delivery 5. Guar Gum and Its Derivatives: Pharmaceutical Applications 6. Pharmaceutical Applications of Locust Bean Gum 7. Pharmaceutical Applications of Sterculia Gum 8. Pharmaceutical Applications of Okra Gum 9. Pharmaceutical Applications of Fenugreek Seed Gum

    5 in stock

    £111.60

  • Natural Polymers for Pharmaceutical Applications:

    Apple Academic Press Inc. Natural Polymers for Pharmaceutical Applications:

    5 in stock

    Book SynopsisMany polymers derived from various marine sources and microorganisms possess some important biological properties such as biocompatibility, biodegradability, and bioadhesivity that make them attractive as pharmaceutical excipients in various pharmaceutical dosage forms. Moreover, these polymers can be modified physically and/or chemically to improve their biomaterial properties.In this volume, Natural Polymers for Pharmaceutical Applications, Volume 2: Marine- and Microbiologically Derived Polymers, looks at how these polymers have been explored and exploited for pharmaceutical uses, such as in tablets, microparticles, nanoparticles, ophthalmic preparations, gels, emulsions, suspensions, etc. Some commonly used marine- and microbiologically derived polymers used as pharmaceutical excipients include alginates, agar-agar, gellan gum, carrageenan; chitosan, xanthan gum, and others. The book focuses on important recent advances from experts around the world on marine-derived polysaccharides and pharmaceutical applications of alginates, agar-agar, gellan gum, carrageenan, chitosan derivatives, xanthan gum. Table of ContentsVolume 2: Marine- and Microbiologically Derived Polymers 1. Marine-Derived Polysaccharides: Pharmaceutical Applications 2. Pharmaceutical Applications of Alginates 3. Pharmaceutical Applications of Agar-Agar 4. Pharmaceutical Applications of Gellan Gum 5. Pharmaceutical Applications of Carrageenan 6. Pharmaceutical Application of Chitosan Derivatives 7. Pharmaceutical Applications of

    5 in stock

    £111.60

  • Drug Development for Cancer and Diabetes: A Path

    Apple Academic Press Inc. Drug Development for Cancer and Diabetes: A Path

    Out of stock

    Book SynopsisKey features include: Details the role of plants for the treatment and management of cancer and diabetes Discusses the role of phytocompounds as ligands for cancer and diabetic targets Reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs Explores the green biosynthesis of nanoparticles and their treatment efficiency Trade Review“This book extrapolates the recent advancements, emerging trends, and novel innovations and speculates about the future perspective in the discovery of drugs for the treatment of cancer and diabetes. As a complete package for the readers, this book provides a valuable window on the revolutionary sector of drug discovery. Part I and Part II of the book together provides comprehensive content to understand the theoretical aspect as well as practical advances and research discoveries. The novel approach of depicting the role of plants and the potential of phytochemi¬cals as antidiabetic and anticancer drugs is a key feature.”—From the Foreword by Dr. P. Padmanabhan, Deputy Director, Lee Kong Chian School of Medicine, Nanyang Technological University, SingaporeTable of ContentsPART I CANCER AND LEADS FOR CANCER TREATMENT 1. Biomarkers for Screening of Premalignant Lesions and Therapeutic Surveillance 2. Kinase Targets in Cancer Drug Discovery 3. Essential Drug Properties and Stages in Anti-Cancer Drug Development 4. Plant Constituent as Anti-Cancer Drugs 5. Anticancer Properties of Some Effective Phytochemicals 6. Therapeutic Aspects of Some Extracts and Purified Cardiac Glycosides Obtained From Nerium oleander L 7. Challenging Compounds of Some Medicinal Plants Against Cancer 8. Medicinal Plants as Therapeutic Agents in the Treatment of Cancer 9. Cytotoxic, Apoptosis Inducing Effects and Anti-Cancerous Drug Candidature of Jasmonates 10. Apoptosis Activity of 1,2,-Benzene Dicarboxylic Acid Isolated from Andrographis paniculata on KB, SiHa and IMR Cancer Cell Line 11. Anticancer Drug Discovery From the Indian Spice Box 12. Phytochemical Investigation and Evaluation of Anti-Breast Cancer Activity of Chloroform Extract of Tagetes erecta 13. Isolation, Identification and In Silico Evaluation of Anticancer Activity of Flavone from Pisum sativum 14. Functional Lead Phytochemicals from the Rutaceae and Zingeiberaceae Plants for Development of Anticancer Drugs 15. In Vitro Anticancer Activity of Biophytum sensitivum on Liver Cancer Lines (HEPG2) 16. Saffron and Its Active Ingredients: A Natural Product with Potent Anticancer Property PART I: ANTIDIABETIC DRUG DISCOVERY 17. Effects of Pterocarpus marsupium in the Management of Type 2 Diabetes Mellitus 18. Antidiabetic and Antihyperlipidemic Activities of Cyathea nilgiriensis (Holttum) on STZ Induced Diabetic Rats 19. Antidiabetic Activity of Drug Loaded Chitosan Nanoparticle 20. Antidiabetic Activity of Silver Nanoparticles Biosynthesized Using Ventilago maderaspatana Leaf Extract 21. Hypoglycemic Activity of Biophytum sensitivum Whole Plant Extracts on Alloxan Induced Diabetic Rats 22. Antidiabetic Activity of Ventilago maderaspatana Leaf Extracts on STZ Induced Diabetic Rats 23. Isolation, Identification, and Molecular Docking of Antidiabetic Compounds of Cyatheia nilgiriensis (Holttum) 24. Antidiabetic Potentials of Major Indian Spices: A Review 25. Aloe Species: Chemical Composition and Therapeutic Uses in Diabetic Treatment

    Out of stock

    £78.84

  • Topical and Transdermal Drug Delivery Systems:

    Apple Academic Press Inc. Topical and Transdermal Drug Delivery Systems:

    1 in stock

    Book SynopsisTopical and transdermal drug delivery systems (TDDs) have several advantages over traditional drug delivery methods, as they can be less invasive, more sanitary, more cost-effective, and may result in better patient compliance. TDDs play a significant role in therapeutics with a variety of preparations and approaches designed by expert formulation scientists. This volume integrates a wide variety of case studies, research, and theories to reveal their diversity and capture the novel approaches of transdermal and topical drug delivery employed by developers and content experts in the field. It provides an abundance of important information and state-of-the-art research on topical and transdermal drug delivery systems and addresses the basics of drug delivery systems, strategies to enhance permeation across membranes, and formulation and evaluation of diverse dosage forms.The volume presents an evaluation of the pros and cons of conventional drug delivery systems against TDDs and discusses the nuances of micro- and nano-systems in TDDs. The extraordinary packages of nano systems (vesicular systems, polymeric nanoparticles, nanoemulsion and dendrimers) are broadly discussed, and their applications are reviewed through a transdermal route.The book looks at TDDs and the main nanoparticles used in skin diseases and lesions of the aging, such as psoriasis, vitiligo, cancer, lesions of the aging and others. Chapters also discuss polymeric micelles in topical and transdermal delivery; microneedles; emulsion, nanoemulsion and microemulsion; TDDs in pulmonary drug delivery systems; nanoencapsulated nasal drug delivery systems; skin sensitivity and irritation testing for transposing transdermal drug delivery systems; and regulatory aspects of drug development for dermal products.Topical and Transdermal Drug Delivery Systems: Applications and Prospects will be a valuable resource for pharmaceutical scientists and researchers, industry professionals, and academicians and students of the pharmaceutical and biomedical sciences.Table of ContentsPART I: BASICS OF TRANSDERMAL DRUG DELIVERY SYSTEMS 1. Concepts and Applications in Topical and Transdermal Drug Delivery 2. Micro- and Nano-Systems in Transdermal Drug Delivery System 3. Advanced Topical and Transdermal Drug Delivery (TTDS) Used in Skin Diseases and Lesions of the Aging PART II: DIVERSE TRANSDERMAL DRUG DELIVERY SYSTEMS 4. Polymeric Micelles in Topical and Transdermal Delivery 5. Microneedles: An Innovative Strategy for Skin Drug Delivery, Diagnostic, and Cosmetologic Approaches 6. Emulsion, Nanoemulsion, and Microemulsion in Tdds 7. Pulmonary Drug Delivery Systems 8. Nanoencapsulated Nasal Drug Delivery System PART III: MISCELLANEOUS 9. Skin Sensitivity and Irritation Testing for Transposing Transdermal Drug Delivery System 10. Regulatory Aspects of Drug Development for Dermal Products

    1 in stock

    £124.45

  • High Throughput Screening Methods: Evolution and

    Royal Society of Chemistry High Throughput Screening Methods: Evolution and

    Out of stock

    Book SynopsisHigh throughput screening remains a key part of early stage drug and tool compound discovery, and methods and technologies have seen many fundamental improvements and innovations over the past 20 years. This comprehensive book provides a historical survey of the field up to the current state-of-the-art. In addition to the specific methods, this book also considers cultural and organizational questions that represent opportunities for future success. Following thought-provoking foreword and introduction from Professor Stuart Schreiber and the editors, chapters from leading experts across academia and industry cover initial considerations for screening, methods appropriate for different goals in small molecule discovery, newer technologies that provide alternative approaches to traditional miniaturization procedures, and practical aspects such as cost and resourcing. Within the context of their historical development, authors explain common pitfalls and their solutions. This book will serve as both a practical reference and a thoughtful guide to the philosophy underlying technological change in such a fast-moving area for postgraduates and researchers in academia and industry, particularly in the areas of chemical biology, pharmacology, structural biology and assay development.Table of ContentsPerspective/overview: State of the art in HTS at the academic-industry interface; Assay design and optimization; Assessment of available compound collections; Novel approaches to discovery and analysis of interesting compound combinations; Modern biophysical methods in target-based screening; Genetic perturbation methods; Understanding luminescence-based screens; Measuring interactions in live cells; Approaches to high-content imaging and multi-feature analysis; Profiling of genetically characterized cell systems; Multidimensional profile-based screening; Using biological systems that better recapitulate physiology; Phenotypic screens with model organisms; Encoded libraries; Modern virtual screening; Research data management; Small molecule bioactivity databases; Chemical biology in a pharma environment; Practical aspects of funding and executing high-throughput screens;

    Out of stock

    £170.05

  • Sustainable Synthesis of Pharmaceuticals: Using

    Royal Society of Chemistry Sustainable Synthesis of Pharmaceuticals: Using

    Out of stock

    Book SynopsisThere is a growing interest in the development of sustainable processes for the synthesis of pharmaceuticals and this book bridges the divide between industrial examples and the fundamental chemistry. It explains the basic principles of using transition metal catalysis with several green approaches for the synthesis of pharmaceuticals. The topic is an important one for green chemistry and the chapters in this book on hydroformylation, green oxidation and olefin metathesis will also be of interest to both medicinal and organic chemists. Written by leading experts in the field, it provides a valuable and easy tool for scientists and industrialists who require information regarding this topic.Table of ContentsIntroduction; Transition Metals in Greener Pharmaceutical Chemistry; Sustainable Synthesis of Pharmaceuticals Using Alternative Techniques: Microwave, Sonochemistry and Mechanochemistry; Carbonylation Reactions in the Synthesis of Pharmaceutically Active Compounds; Applications of Catalytic Hydroformylation in the Synthesis of Biologically Relevant Synthons and Drugs; Transfer Hydrogenation with Non-toxic Metals for Drug Synthesis; Green Metal-catalysed Synthesis of Pharmaceutically Useful Asymmetric Epoxides and Sulfoxides; C–C Bond Formation in the Sustainable Synthesis of Pharmaceuticals; Metal-catalysed Metathesis Reactions for Greener Synthon/Drug Synthesis; Tetravalent Boron-based Therapeutics

    Out of stock

    £151.05

  • Pharmaceutical Crystallography: A Guide to

    Royal Society of Chemistry Pharmaceutical Crystallography: A Guide to

    Out of stock

    Book SynopsisThe pharmaceutical industry has become acutely aware of the importance of the solid state, but pharmaceutical scientists often lack specific training in topics related to solid-state structure and crystallography. This book provides needed support in this topical area. Taking an intuitive and informal approach to solid-state structure and crystallographic concepts, this book is written for anyone who needs a clear understanding of modern crystallography, with specific reference to small-molecule pharmaceutical solids. The author describes molecular crystals and crystal structures, symmetry, space groups, single-crystal and powder X-ray diffraction techniques and the analysis and interpretation of crystallographic data. Useful technical details are presented where necessary and case studies from the pharmaceutical literature put theory into a practical context. Written by an internationally leading figure and with its focus on molecular crystals, this book is equally applicable to chemists with a need to understand and apply X-ray crystal-structure determination.Table of ContentsPharmaceutical Solids; What Defines a Crystal?; Symmetry in Crystals; Space Groups; Planes and Crystal Morphology; Crystal Structures and Diffraction Patterns; Symmetry in Diffraction Patterns; Single-crystal X-ray Diffraction (Part 1); Single-crystal X-ray Diffraction (Part 2); Powder X-ray Diffraction; Solving X-ray Crystal Structures; Refining X-ray Crystal Structures; Disorder and Twinning; Crystallographic Results

    Out of stock

    £42.75

  • Getting Research Published: An A-Z of Publication

    Taylor & Francis Ltd Getting Research Published: An A-Z of Publication

    15 in stock

    Book SynopsisThe third edition of this popular and highly-regarded guide uncovers the ethics, conventions and often unwritten rules of publishing in peer-reviewed journals and at conferences. It provides clear direction on how to choose the right journal, avoid publication delays, resolve authorship disputes and many other problems associated with being published that pose challenges to new and experienced researchers alike.The A to Z format is highly accessible to readers with different backgrounds and varying levels of publication experience, including students and healthcare professionals, medical researchers and individuals working in drug companies and communications agencies. It will be particularly valuable to anyone involved in planning publications.Trade Review"In short, this is a must-have book for writers, editors and account managers in medical communications agencies in the publications departments of research institutions and pharmaceutical and medical device companies. I also recommend it to my fellow freelance writers as an easy way to ensure that you are ‘on the same page’ as the companies that you are working with when it comes to disseminating medical research findings" – Jane Tricker CMPP, Medical Writing"Like its predecessors this update of Liz Wager’s book is presented concisely, pragmatically and with the inimitable down-to-earth and sharp-witted style familiar to many of us...this book is the source of "Everything You Need to Know About Medical Publishing but Were Afraid to Ask" and could well be one of the best bookshelf investments you make this year". – Moira A Hudson, European Science Editing Journal"The 3rd edition of Getting Research Published successfully instructs in an authoritative, easy to use, and clear and concise manner."—Howard Bauchner, MD, Editor in Chief, JAMA and The JAMA Network "The first thing that strikes you about this book … is its sheer practical nature."—Peter Thorpe, Independent consultant in information and communications management, European Science Editing Journal (of a previous edition)Table of ContentsPUBLICATION STRATEGY – AN OVERVIEW. Step-by-Step Guide to Publication Strategy. Developing a Publication Plan for a Multicentre Study. How Long Will it Take? Working with a Medical Writer. Dr. Seymour and the Disappearing Paper: A Cautionary Tale. A TO Z OF PUBLICATION STRATEGY.

    15 in stock

    £37.99

  • Plant-derived Pharmaceuticals: Principles and

    CABI Publishing Plant-derived Pharmaceuticals: Principles and

    15 in stock

    Book SynopsisDescribing recent developments in the engineering and generation of plants as production platforms for biopharmaceuticals, this book includes both vaccines and monoclonal antibodies. It has a particular emphasis on targeting diseases which predominate in less developed countries, encompassing the current state of technologies and describing expression systems and applications. This book also includes a variety of vaccine case studies, protecting against pervasive infectious diseases such as rabies, influenza and HIV.Table of Contents1: Introduction, and the Promise of a Plant-derived Vaccine for Hepatitis B Virus 2: Protein Body-inducing Fusions for Recombinant Protein Production in Plants 3: Expression of Recombinant Proteins in Plant Cell Culture 4: Plant-derived Monoclonal Antibodies as Human Biologics for Infectious Disease and Cancer 5: Plant-produced Virus-like Particles 6: Expression of the Capsid Protein of Human Papillomavirus in Plants as an Alternative for the Production of Vaccines 7: Patenting of Plant-made Recombinant Pharmaceuticals and Access in the Developing World 8: Case Study 1: Rabies 9: Case Study 2: Plant-made HIV Vaccines and Neutralizing Antibodies 10: Case Study 3: The Search for a Plant-made Vaccine for Pandemic Influenza Virus

    15 in stock

    £41.79

  • Stimuli-responsive Drug Delivery Systems

    Royal Society of Chemistry Stimuli-responsive Drug Delivery Systems

    Out of stock

    Book SynopsisThe increased understanding of molecular aspects associated with chronic diseases, such as cancer and the role of tumor microenvironment, has led to the identification of endogenous and exogenous stimuli that can be exploited to devise “stimuli-responsive” materials for site-specific drug delivery applications. This book provides a comprehensive account on the design, materials chemistry, and application aspects behind these novel stimuli-responsive materials. Setting the scene, the editors open with a chapter addressing the need for smart materials in delivery applications for therapy, imaging and disease diagnosis. The following chapter describes the key physical and chemical aspects of smart materials, from lipids to polymers to hybrid materials, providing the reader with a springboard to delve into the more application oriented chapters that follow. With in-depth coverage of key drug delivery systems such as pH-responsive, temperature responsive, enzyme-responsive and light responsive systems, this book provides a rigorous foundation to the field. A perfect resource for graduate students and newcomers, the closing chapter on regulatory and commercialization challenges also makes the book ideal for those wanting to take the next step towards clinical translation.Table of ContentsFundamentals of Stimuliresponsive Drug and Gene Delivery Systems; Materials and Chemistry of Stimuli-responsive Drug Delivery Systems; pH-responsive Drug Delivery Systems; Thermo-responsive Nanomedicines for Drug Delivery in the Gastrointestinal Tract; Redox-responsive Drug Delivery Systems; Magnetically-responsive DDS; Light-responsive Drug Delivery Systems; Integrated Polymer Composites for Electro-responsive Drug Delivery; Enzyme-responsive Drug Delivery Systems; Swelling-controlled Drug Delivery Systems; Biologically-inspired Stimuli-responsive DDS; Stimuli-responsive Materials in Theranostics; Stimuli-responsive Material Inspired Drug Delivery Systems and Devices; Regulatory and Commercialization Challenges with Stimuli-responsive Nanomedicines

    Out of stock

    £151.05

  • Co-crystals: Preparation, Characterization and

    Royal Society of Chemistry Co-crystals: Preparation, Characterization and

    Out of stock

    Book SynopsisMulti-component crystalline systems or co-crystals have received tremendous attention from academia and industry alike in the past decade. Applications of co-crystals are varied and are likely to positively impact a wide range of industries dealing with molecular solids. Co-crystallization has been used to improve the properties and performance of materials from pharmaceuticals to energetic materials, as well as for separation of compounds. This book combines co-crystal applications of commercial and practical interest from diverse fields in to a single volume. It also examines effective structural design of co-crystals, and provides insights into practical synthesis and characterization techniques. Providing a useful resource for postgraduate students new to applied co-crystal research and crystal engineering, it will also be of interest to established researchers in academia or industry.Trade ReviewI would say that one would be able to access information—and again I say, in a fast moving field—from this book far easier than using a panoply of computer aided information gathering methods. In this respect, this particular volume is a success and I congratulate the editors and the authors. -- Gautam R. Desiraju, Indian Institute of Science, India * Acta Cryst., 2019, B75, 914–915, https://doi.org/10.1107/S2052520619012642 *The editors of the present book on cocrystals have done an admirable job and have even exceeded expectations in providing us with a timely and extremely useful book - and this is an added challenge - in a fast moving area of fundamental and practical importance. -- Gautam R. Desiraju, Indian Institue of Science, India * Acta Cryst., 2019, B75, 914–915, https://doi.org/10.1107/S2052520619012642 *Table of ContentsCo-crystals: Introduction and Scope; The Role of Hydrogen Bonding in Co-crystals; Design and Structural Chemistry of Halogen-bonded Co-crystals; Mechanochemistry in Co-crystal Synthesis; Pharmaceutical Co-crystals—Molecular Design and Process Development; Co-crystallization of Energetic Materials; Paramagnetic Organic Co-crystals of Neutral or Ionic Radicals; Hydrogen-bonded Semiconductor Co-crystals; Co-crystallization as a Versatile Tool in Separations Technology

    Out of stock

    £151.05

  • The Handbook of Continuous Crystallization

    Royal Society of Chemistry The Handbook of Continuous Crystallization

    Out of stock

    Book SynopsisContinuous crystallization is an area of intense research, with particular respect to the pharmaceutical industry and fine chemicals. Improvements in continuous crystallization technologies offer chemical industries significant financial gains, through reduced expenditure and operational costs, and consistent product quality. Written by well-known leaders in the field, The Handbook of Continuous Crystallization presents fundamental and applied knowledge, with attention paid to application and scaling up, and the burgeoning area of process intensification. Beginning with concepts around crystallization techniques and control strategies, the reader will learn about experimental methods and computational tools. Case studies spanning fine and bulk chemicals, the pharmaceutical industry, and employing new mathematical tools, put theory into context.Table of ContentsNucleation and Crystal Growth in Continuous Crystallization; Fundamentals of Population Balance Based Crystallization Process Modeling; Continuous Crystallisation With Oscillatory Baffled Crystalliser Technology; Process Control; Slug-flow Continuous Crystallization: Fundamentals and Process Intensification; Continuous Crystallization of Bulk and Fine Chemicals; Process Intensification in Continuous Crystallization; Continuous Melt Crystallization; Continuous Enantioselective Crystallization of Chiral Compounds; Continuous Isolation of Active Pharmaceutical Ingredients; Continuous Eutectic Freeze Crystallization; Economic Analysis of Continuous Crystallization; Digital Design and operation of Continuous Crystallization Processes via Mechanistic Modelling Tools

    Out of stock

    £118.75

  • Metal-based Anticancer Agents

    Royal Society of Chemistry Metal-based Anticancer Agents

    Out of stock

    Book SynopsisMetal-based anticancer drugs are among the most successful therapeutic agents, as evidenced by the frequent prescription of selected platinum and arsenic compounds to patients. Metal-based Anticancer Agents covers the interdisciplinary world of inorganic drug discovery and development by introducing the most prominent compound classes based on different transition metals, discussing emerging concepts and enabling methods, as well as presenting key pre-clinical and clinical aspects. Recent progress on the unique features of next-generation targeted metal-based anticancer agents, including supramolecular coordination complexes used for both therapy and drug delivery, promise a bright future beyond the benefits of pure cytotoxic activity. With contributions from global leaders in the field, this book will serve as a useful reference to established researchers as well as a practical guide to those new to metallodrugs, and postgraduate students of medicinal chemistry and metallobiology.Table of ContentsEnhancing the Therapeutic Potential of Platinum-Based Anti-Cancer Agents by Incorporating Clinically Approved Drugs as Ligands; Ruthenium, Osmium and Iridium in the Fight Against Cancer; Iron Compounds as Anticancer Agents; Recent Advances in Anticancer Copper Compounds; Anticancer Gold Compounds; Heterometallic Complexes as Anticancer Agents; Vanadium Compounds as Enzyme Inhibitors with a Focus on Anticancer Effects; Arsenic-based Anticancer Agents; Supramolecular Metal-based Structures for Applications in Cancer Therapy; Enabling Methods to Elucidate the Effects of Metal-based Anticancer Agents; Metal-Based Radiotherapeutics; Challenges and Chances in the Pre-clinical to Clinical Translation of Anticancer Metallodrugs

    Out of stock

    £170.05

  • Vaccine Development: From Concept to Clinic

    Royal Society of Chemistry Vaccine Development: From Concept to Clinic

    Out of stock

    Book SynopsisVaccine development is a complex and time consuming process that differs from the development of conventional pharmaceuticals. Primarily, vaccines are intended for use in healthy individuals as a preventative measure, requiring a long and rigorous process of research and many years of testing and development prior to clinical trials and regulatory approval. The average time for the development of vaccines to clinical is 12 to 15 years. Vaccine Development: From Concept to Clinic is a detailed overview of the development of new vaccines, covering the entire process and addresses all classes of vaccines from a processing, development and regulatory viewpoint. Utilising successful case studies the book will provide insight to the issues scientists face when producing a vaccine, the steps involved and will serve as an ideal reference tool regarding state-of-the-art vaccine development. This book is an ideal companion for any researchers working in vaccine discovery and development or with an interest in the field.Table of ContentsVaccine Development: From Concept to Clinic; Pre-clinical Safety Assessment Considerations for Vaccine Development; Clinical Trials in the Development of Vaccines for Infectious Diseases; Clinical Trials in Immunotherapeutic Vaccine Development; Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs against COVID-19; High Throughput Assays for Clinical Development; Virus-like Particle Based Vaccines: GARDASIL®; Cell Culture-based Influenza Vaccine Development; Conjugate Vaccines: Design and Development Considerations; Vaccine Adjuvants: Mechanisms of Action; Development Considerations for Final Dosage Forms: Mucosal Bacterial Vaccines; Exploiting Glycans in Vaccine Design; The PATH Experience in Vaccine Development Partnerships with Manufacturers from Emerging Markets

    Out of stock

    £151.05

  • The Handbook of Medicinal Chemistry: Principles

    Royal Society of Chemistry The Handbook of Medicinal Chemistry: Principles

    Out of stock

    Book SynopsisCompletely revised and updated, the 2nd edition of The Handbook of Medicinal Chemistry draws together contributions from authoritative practitioners to provide a comprehensive overview of the field as well as insight into the latest trends and research. An ideal companion for students in medicinal chemistry, drug discovery and drug development, while also communicating core principles, the book places the discipline within the context of the burgeoning platform of new modalities now available to drug discovery. The book also highlights the role chemistry has to play in wider target validation and translational technologies. This is a carefully curated compilation of writing from global experts using their broad experience of medicinal chemistry, project leadership and drug discovery and development from an industry, academic and charity perspective to provide unparalleled insight into the field.Table of ContentsPhysicochemical Properties; Synthesis in Medicinal Chemistry; Useful Computational Chemistry Tools for Medicinal Chemistry; Structure-based Design for Medicinal Chemists; Fragment-based Ligand Discovery; Machine Learning in Drug Design; Drug Metabolism; ADME Optimization in Drug Discovery; Molecular Biology for Medicinal Chemists; Assays; In Vitro Biology: Measuring Pharmacological Activity That Will Translate to Clinical Efficacy; Animal Models: Practical Use and Considerations; Bioinformatics for Medicinal Chemistry; Translational Science; Discovery Toxicology in Lead Optimization; Toxicology and Drug Development; Patents for Medicines; Target Validation for Medicinal Chemists; Lead Optimisation: What you should know!; Pharmaceutical Properties – The Importance of Solid Form Selection; The Medicinal Chemistry and Process Chemistry Interface; Clinical Drug Development; SMN2 Splicing Modification by Small Molecules – A Blueprint to Tackle the Underlying Genetic Cause of Many Underserved Diseases; The Discovery of Checkpoint Kinase 1 Inhibitors: From Fragments to Clinical Candidate; Medicinal Chemistry for Neglected Diseases – Malaria, Tuberculosis, Sleeping Sickness, Leishmaniasis and River Blindness; New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery

    Out of stock

    £90.25

  • Drug Repurposing

    Royal Society of Chemistry Drug Repurposing

    Out of stock

    Book SynopsisDrug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. But repurposing also requires a fresh look at configuring pharmaceutical R&D, considering clinical, regulatory and patent issues much earlier than would otherwise be the case; a holistic gedanken experiment almost needs to be undertaken at the very start of any repurposing development. In addition to new ways of thinking, the discovery of repurposing opportunities can take advantage of artificial intelligence techniques to match the perfect new use for an existing drug. And while repurposing of medicines has been in the mind of every doctor since Hypocrates, modern clinical practice will simply have to adapt to new repurposing techniques in an age where the number of known diseases is increasing much faster than the healthcare dollars available.Table of ContentsIntroduction and Historical Overview of Drug Repurposing Opportunities; Role of Academia: Drug Repurposing to Induce Autophagy for Treatment of Neurodegenerative Diseases; The Role of Clinical Medicine; Role of Industry; Collaboration Models for Repurposing; Screening Technologies; Cheminformatics Data Mining and Modeling for Drug Repurposing; Using Artificial Intelligence for Drug Repurposing; Field Discoveries (Case Reports); Preclinical. A Repurposed Novel Lyn Kinase Activator, MLR-1023, is a Model Example of Pharmacological Pleiotropy; Harnessing the Potential of Early Access: Advancing Timely Patient Access to Innovative Medicines in a Sustainable Way; Adapting Payers’ and Producers’ Incentives to Drug Repurposing; Intellectual Property Considerations; Regulatory Considerations and Strategies for Drug Repositioning; Future Perspectives in Drug Repurposing

    Out of stock

    £160.55

  • Polysaccharide-based Biomaterials: Delivery of

    Royal Society of Chemistry Polysaccharide-based Biomaterials: Delivery of

    Out of stock

    Book SynopsisPolysaccharides are natural, renewable materials that are biodegradable and biocompatible, making them ideal subjects for biomedical applications. This book focusses on the main polysaccharides, including but not limited to chitosan, cellulose, alginate, dextran, guar gum, gellan gum, pullulan, locust bean gum, pectin, xanthan gum, starch, hyaluronan and carrageenan, and their applications in drug delivery, imaging and tissue engineering. With contributions from around the world, the editors have pulled together a tightly curated set of chapters which showcase how polysaccharide-based materials are employed in a range of biomedical systems. The end result is a book in which the reader can gain a sound overview of this important class of material for biomedical applications, without scouring journal articles. Those working in materials science, biomedical and chemical engineering, and pharmaceutical technologies will find this a must-have reference.Table of ContentsPolysaccharide-based Biomaterials: Overview;Recent Approaches in Alginate-based Carriers for Delivery of Therapeutics and Biomedicine;Alginate-based Carriers for Transdermal Drug Delivery;Chitosan-based Nanocarriers for Drug Delivery: Advances and Challenges;Hyaluronic Acid in Drug Delivery;Dextran in Delivery of Therapeutics: Chronicle of the Journey from Preclinical to Clinical Trials;Guar Gum-based Biomaterials in Delivery of Therapeutics;Gellan Gum-based Drug Delivery Carriers;Locust Bean Gum - A Potential Drug Delivery Carrier;Pectin-based Vehicles for Delivery of Therapeutics;Pullulan in the Delivery of Therapeutics;Carrageenan-based Carriers for Therapeutic Delivery;Xanthan Gum in Drug Carriers;Cellulose-based Biomaterials in Drug Delivery Applications;Starch-based Drug Delivery System: A Review on Pharmaceutical and Biomedical Applications;Tamarind Seed Polysaccharide in Novel Drug Delivery and Biomedical Applications;Chitosan-derived Biomaterials in Cancer Therapeutics and Biomedical Imaging;Polysaccharide-based Scaffolds for Tissue Engineering Application

    Out of stock

    £189.05

  • Carrier-mediated Gene and Drug Delivery for

    Royal Society of Chemistry Carrier-mediated Gene and Drug Delivery for

    Out of stock

    Book SynopsisWound healing following trauma, illness, or surgery is a complex process and is comprised of a particularly fragile sequence of biochemical events that are susceptible to interruption or failure, which can lead to non-healing chronic wounds, scarring and other issues. Non-healing wounds are also commonly associated with diabetes, arterial disease, infection, and the metabolic deficiencies of aging. Treatment of dermal wounds can therefore be challenging, and as such the ability to localise the effect of drugs and treatments to promote healing through protective materials is an attractive area of research. This book introduces the essential areas of skin anatomy and the wound healing process, and how this can be disrupted by various pathologies, and proceeds to outline how biomaterials and devices for dermal drug delivery (including controlled delivery via stimuli-responsive devices) can be utilised in effective wound management. This book is an ideal companion for postgraduates and researchers in a variety of disciplines including biomedical engineering, biomaterials, drug development and delivery, formulation science and tissue engineering.Table of ContentsIntroduction;Skin Anatomy;Cutaneous Barrier and Skin Infections;The Wound Healing Process;Infections;Antibacterial and Antifungal Materials;Pharmaceutical Compounds with Antioxidant Properties;Antioxidant Carriers;Gene Delivery; Drug Delivery;Stimuli-responsive Systems for Wound Healing;Stimuli-responsive Systems: External Triggers;Safety, Regulation, and Clinical Translation

    Out of stock

    £151.05

  • Organic Chemistry of Drug Degradation

    Royal Society of Chemistry Organic Chemistry of Drug Degradation

    1 in stock

    Book SynopsisThe vast majority of drugs are organic molecular entities. A clear understanding of the organic chemistry of drug degradation is essential to maintaining the stability, efficacy, and safety of a drug product throughout its shelf-life. During analytical method development, stability testing, and pharmaceutical manufacturing troubleshooting activities, one of the frequently occurring and usually challenging events would be the identification of drug degradants and understanding of drug degradation mechanisms and pathways. This book is written by a veteran of the pharmaceutical industry who has first-hand experience in drug design and development, drug degradation mechanism studies, analytical development, and manufacturing process troubleshooting and improvement. The author discusses various degradation pathways with an emphasis on the mechanisms of the underlying organic chemistry, which should aid greatly in the efforts of degradant identification, formulation development, analytical development, and manufacturing process improvement. Organic reactions that are significant in drug degradation will first be reviewed and then illustrated by examples of drug degradation reported in the literature. The author brings the book to a close with a final chapter dedicated to the strategy for rapid elucidation of drug degradants with regard to the current regulatory requirements and guidelines. One chapter that should be given special attention is Chapter 3, Oxidative Degradation. Oxidative degradation is one of the most common degradation pathways but perhaps the most complex one. This chapter employs more than sixty drug degradation case studies with in-depth discussion in regard to their unique degradation pathways. With the increasing regulatory requirements on the quality and safety of pharmaceutical products, in particular with regard to drug impurities and degradants, the book will be an invaluable resource for pharmaceutical and analytical scientists who engage in formulation development, analytical development, stability studies, degradant identification, and support of manufacturing process improvement. In addition, it will also be helpful to scientists engaged in drug discovery and development as well as in drug metabolism studies.Trade Review"...the book provides the interested reader with a comprehensive, overview on all relevant aspects of drug degradation chemistries and analytical strategies." -- Prof. Dr. Mario Thevis, German Sport University Cologne (Germany) * ChemMedChem, DOI: 10.1002/cmdc.201300109 *"Overall, Organic Chemistry of Drug Degradation is an interesting read and provides the reader with concise information and up-to-date knowledge on chemical as well as analytical aspects of drug degradation." -- Prof. Dr. Mario Thevis, German Sport University Cologne (Germany) * ChemMedChem, DOI: 10.1002/cmdc.201300109 *"Due to the book’s broad scope and well-balanced coverage of obligatory and new aspects in drug stability research and quality assurance, it is of particular value to students and scientists in the field of pharmaceutical sciences." "The book superbly introduces a broad readership into the arena of drug degradation and impurity testing." -- Prof. Dr. Mario Thevis, German Sport University Cologne (Germany) * ChemMedChem, DOI: 10.1002/cmdc.201300109 *Table of ContentsIntroduction; Hydrolytic Degradation; Oxidative Degradation; Various Types and Mechanisms of Degradation Reactions; Drug-Excipient Interactions and Adduct Formation; Photochemical Degradation; Chemical Degradation of Biological Drugs; Strategies for Elucidation of Degradant Structures and Degradation Pathways; Control of Drug Degradation; Subject index

    1 in stock

    £146.29

  • Macrocycles in Drug Discovery

    Royal Society of Chemistry Macrocycles in Drug Discovery

    Out of stock

    Book SynopsisThis book reviews macrocycles in drug discovery, both those of natural origin and semi-synthetic derivatives of natural products, and those designed and synthesized based on principles of medicinal chemistry. The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules. A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.Trade Review"Macrocycles in Drug Discovery" provides an in-depth review with case studies of some of the major targets and areas that have been the focus of macro- cyclic drug discovery. It also provides useful insights into macrocycle cell permeability, oral bioavailability and methods for their synthesis." "...rich in information..." "I absolutely recommend "Macrocycles in Drug Discovery" to those that are active in the field, both in academia and the pharmaceutical industry. The different chapters provide stimulating reading for experts in macrocycles as well as for organic chemists and medicinal chemists in general. The comprehensive chapters also serve as a source of references with extensive citation of the primary literature." -- Prof. Jan Kihlberg Chemmedchem review in March 2015 issue "The book is a wellmade snapshot of current research, describing development stories of established macrocycle drugs and their properties, as well as new avenues in their development." "The book's 11 chapters, written by distinguished experts, are mostly dedicated to macrocycles for a specific protein target or target class." "Numerous examples presented along with the compounds' potency, selectivity, permeability, bioavailability and other properties allow the reader to understand which determinants make a successful macrocyclic drug." -- Christian Heinis Chemistry World Macrocycles are usually defined as having a structure that includes a ring of 12 or more heavy atoms. They are an interesting class of small molecules that have found wide use as antibiotics, as therapeutic agents in oncology, and for immunosuppression, but also across a large number of other indications. Many macrocyclic drugs are natural products that were isolated and discovered prior to the emergence of target- based drug discovery and high-through- put screening. Despite this precedent, macrocycles were largely out of focus in drug discovery research for a number of years. Interest in macrocycles has undergone a major revival over the past decade for several reasons. It has been argued that too strict an implementation of the Lipinski's rule of five (Ro5) has hampered the pharmaceutical industry from seizing opportunities involving novel but difficult targets. This has put the spotlight on compounds outside the Ro5 as tool agents in chemical biology and as leads for drug discovery. Macrocycles are of particular prominence in this space as they have been hypothesized to be better suited to modulate difficult targets with large and flat binding sites be- cause of their size, shape and flexibility. In addition, a number of natural-product-based and designed macrocycles are also cell permeable and orally bioavailable, making them of particular interest among the drugs outside the Ro5 guide- lines. "Macrocycles in Drug Discovery" provides an in-depth review with case studies of some of the major targets and areas that have been the focus of macro- cyclic drug discovery. It also provides useful insights into macrocycle cell permeability, oral bioavailability and methods for their synthesis. As Nature is the main source of macrocyclic drugs, it is appropriate that Chapter 1 of the book provides an overview of different classes of macrocyclic natural products. This ranges from sources of isolation and bio- synthesis, via synthetic approaches, to pharmacological activities and clinical applications. Chapter 1, as all chapters in the book, is rich in information and therefore not bedside reading unless you are an expert in the field. In general, Chapters 2-7 review and discuss how macrocycles have been dis- covered and developed to modulate different targets of interest for the treatment of disease. Each chapter starts with an introduction to the field to whet the appetite of the reader, followed by a systematic overview of data and insights gathered, such as for different classes of macrocycles. These chapters also provide important lessons from historical macro- cycle drug discovery. Thus, macrocycles that target heat shock protein 90 (Hsp90), epothilones as stabilizers of microtubules, inhibitors of zinc-dependent histone deacetylases (HDACs) and macrocyclic kinase inhibitors, which are all used in oncology, are reviewed in Chapters 2-5. Chapters 6 and 7 discuss the use of anti-inflammatory macrolides to manage chronic neutrophilic inflammation and the recent discoveries of hepatitis C virus protease inhibitors. Chapter 8 provides an impressive overview of how cyclic mimetics of protein epitopes have been developed to target G-protein-coupled receptors (GPCRs), integrins and protein-protein interactions (PPIs). In line with this theme, Chapter 9 is focused on macrocyclic a-helical peptides, in particular stapled peptides and their use to inhibit PPIs. Last but not least, Chapters 10 and 11 provide general and extensive overviews of properties that influence cell permeability and oral bioavailability of macrocycles, as well as methods for their synthesis, respectively. Chapter 10 has a particularly interesting introductory section on modelling of permeability and absorption. This is followed by a brief overview of oral bioavailability of macrocycles, which can be supplemented from citations throughout the book, particularly those in the introduction of Chapter 1. Chapter 11 provides a very extensive review of how macrocycles have been synthesized (434 references), but is easy to access from its systematic organization by the methodology used for the macrocyclization step. In particular, the section on how macrocyclizations have been scaled up in process chemistry departments illustrates how far chemistry has progressed in this field during recent years. Additional reading to this section should include the use of diversity- oriented synthesis (DOS) to generate synthetic libraries of macrocycles for drug discovery. All books will have some drawbacks and omissions; a few minor ones have been alluded to above in the overview of the different chapters. Additional topics that readers should be aware of include cyclosporine A for which substantial studies have been undertaken to explain how it crosses cell membranes. These studies form a historical basis for which current research aimed at identifying strategies for design of cell-permeable cyclic peptides are based. Chapter 9 on stapled peptides is written with a very optimistic viewpoint that differs somewhat from current discussions in the primary literature, as well as the more stringent tone of the other chapters. It would have benefitted from a more extensive discussion of cell penetration of macrocyclic a-helical peptides. As written, the reader is left with the understanding that stapled peptides rely on active transport processes to enter cells, where they then elicit their pharmacological effect. However, a discussion of the current research on whether these transport processes allow general and re- producible drug delivery to a diverse population of patients is lacking. Another lingering question is whether or not there are limitations to whether stapled peptides reach their destinations inside the cell after active uptake. In spite of the minor concerns indicated above, I absolutely recommend "Macrocycles in Drug Discovery" to those that are active in the field, both in academia and the pharmaceutical industry. The different chapters provide stimulating reading for experts in macrocycles as well as for organic chemists and medicinal chemists in general. The comprehensive chapters also serve as a source of references with extensive citation of the primary literature. In addition, the chapters are well organized, and it is therefore easy to locate the reader's particular topic of interest. However, "Macrocycles in Drug Discovery" is best red one chapter at a time, not from cover to cover, due to the vast amount of information it summarizes. Each reader that has taken the time to carefully read through this book will be better positioned for retrospective analysis of macrocyclic drug discovery and speculation on what the future may look like. -- Prof. Jan Kihlberg, Uppsala University (Sweden) Chemmedchem review in March 2015 issue Macrocycles are ring-shaped molecules containing12 or more ring atoms. Many important drugs belong to this structural class, for example the immunosuppressant cyclosporine or the antibiotic vancomycin. Macrocycles' ability to bind difficult targets that are considered 'undruggable' by traditional small molecule drugs has produced much interest. Recent innovations for designing de novo macrocycles and for screening large combinatorial macrocycle libraries have given an additional impulse to the field's development. The book is a well-made snapshot of current research, describing development stories of established macrocycle drugs and their properties, as well as new avenues in their development. The book's 11chapters, written by distinguished experts, are mostly dedicated to macrocycles for a specific protein target or target class. The targets discussed include heat shock protein, tubulin, histone deacetylases, kinases, proteases, G-protein coupled receptors, integrins, and protein- protein interactions. Several authors provide introductory sections about the general characteristics of macrocycles, meaning that there is a small overlap between some chapters. However, this is not negative at all as it offers different perspectives on the topic. Most established macrocyclic drugs are based on natural products that were identified in bacteria, fungi, plants or other organisms. Consequently, the majority of molecules discussed are natural products or derivatives thereof. As nature does not offer macrocycles for every therapeutic target, scientists have designed new macrocycles, which are also covered in the book. Chapters are dedicated to the design of kinase inhibitors and to intriguing strategies for developing macrocycles de novo by mimicking protein epitopes such as hairpins or helices. To develop novel macrocycles, it is essential to understand the factors that affect their permeability and bioavailability-important topics that are discussed in the penultimate chapter. The book concludes with a comprehensive chapter on synthetic strategies for the production of macrocycles. In summary, this title is an in depth discussion of macrocycle drug discovery. Numerous examples presented along with the compounds' potency, selectivity, permeability, bioavailability and other properties allow the reader to understand which determinants make a successful macrocyclic drug. -- Christian Heinis Chemistry WorldTable of ContentsIntroduction; Bioactive Macrocycles from Nature; Recent Advances in Macrocyclic Hsp90 Inhibitors; Epothilones; Macrocyclic Inhibitors of Zinc-dependent Histone Deacetylases (HDACs); Designed Macrocyclic Kinase Inhibitors; Anti-Inflammatory Macrolides to Manage Chronic Neutrophilic Inflammation; Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors; Macrocyclic Inhibitors of GPCR’s, Integrins and Protein–Protein Interactions; Macrocyclic a-Helical Peptide Drug Discovery; Optimizing the Permeability and Oral Bioavailability of Macrocycles; The Synthesis of Macrocycles for Drug Discovery

    Out of stock

    £166.25

  • Pharmaceutical Formulation: The Science and

    Royal Society of Chemistry Pharmaceutical Formulation: The Science and

    Out of stock

    Book SynopsisFormulation is a key step in the drug design process, where the active drug is combined with other substances that maximise the therapeutic potential, safety and stability of the final medicinal product. Modern formulation science deals with biologics as well as small molecules. Regulatory and quality demands, in addition to advances in processing technologies, result in growing challenges as well as possibilities for the field. Pharmaceutical Formulation provides an up to date source of information for all who wish to understand the principles and practice of formulation in the drug industry. The book provides an understanding of the links between formulation theory and the practicalities of processing in a commercial environment, giving researchers the knowledge to produce effective pharmaceutical products that can be approved and manufactured. The first chapters introduce readers to different dosage forms, including oral liquid products, topical products and solid dosage forms such as tablets and capsules. Subsequent chapters cover pharmaceutical coatings, controlled release drug delivery and dosage forms designed specifically for paediatric and geriatric patients. The final chapter provides an introduction to the vital role intellectual property plays in drug development. Covering modern processing methods and recent changes in the regulatory and quality demands of the industry, Pharmaceutical Formulation is an essential, up to date resource for students and researchers working in academia and in the pharmaceutical industry.Table of ContentsPreformulation Studies; Hard Capsules in Modern Drug Delivery; Soft Capsules; Tablet Formulation; Suspension Quality by Design; Excipients: Kano Analysis and Quality by Design; Film Coating of Tablets; Oral Controlled Release Technology and Development Strategy; Less Common Dosage Forms; Paediatric Pharmaceutics - The Science of Formulating Medicines for Children; The Formulation of Biological Molecules; Intellectual Property; User-friendly Medicines

    Out of stock

    £160.55

  • Prescribing Skills Workbook

    JP Medical Ltd Prescribing Skills Workbook

    Out of stock

    Book SynopsisPrescribing Skills Workbook is the ideal way for students and junior doctors to practice prescribing. The book features 45 exercises, each one carefully chosen to test the reader’s grasp of a key principle, such as managing a patient on warfarin. Each exercise begins with a short clinical scenario; next, the reader is invited to fill in a realistic, life-size chart in response; an answer section follows containing the correctly completed chart, together with a summary of the main clinical and educational aspects of the exercise. A unique resource for medical students and junior doctors to improve their understanding of the principles of safe prescribing and practice filling out a drug chart correctly 45 life-size charts replicate the experience of completing a prescription, with 45 corresponding charts filled out correctly to compare, identify and rectify errors DRUGCHARTS mnemonic systematically highlights the key items to consider when prescribing Key points boxes highlight the main learning objectives Introductory chapter includes tips for safe prescribing Table of ContentsIntroduction Exercise 1 Basic skills Exercise 2 Maintenance fluids Exercise 3 Awkward medications Exercise 4 Preoperative assessment Exercise 5 Postoperative complications Exercise 6 Postoperative pain relief Exercise 7 Vomiting Exercise 8 Renal failure Exercise 9 Chest pain Exercise 10 Warfarin interactions Exercise 11 Dysphagia Exercise 12 Anaphylaxis Exercise 13 Shortness of breath Exercise 14 Fluid prescribing in hypotension Exercise 15 Paediatric fluid prescribing Exercise 16 Fluid prescribing in epigastric pain Exercise 17 Prescribing blood Exercise 18 Electrolyte replacement Exercise 19 Heparin infusions Exercise 20 Paracetamol overdose Exercise 21 Hyperkalaemia Exercise 22 Hypovolaemic shock Exercise 23 Preoperative assessment in diabetes Exercise 24 Prescribing in pregnancy Exercise 25 Breastfeeding Exercise 26 Poor oral intake Exercise 27 Atrial fibrillation Exercise 28 Acute coronary syndrome Exercise 29 Alcohol withdrawal Exercise 30 Antibiotics Exercise 31 Regular medications Exercise 32 Nil-by-mouth patient Exercise 33 Warfarin therapy Exercise 34 Prescribing gentamicin Exercise 35 Headache Exercise 36 Paediatric prescribing Exercise 37 Palliative care Exercise 38 Sore throat Exercise 39 Thromboprophylaxis Exercise 40 Pain management Exercise 41 Oliguria Exercise 42 Confusion in the elderly Exercise 43 Analgesia Exercise 44 Insomnia Exercise 45 Unresponsive patient

    Out of stock

    £28.50

© 2025 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account